Document:

Exhibit 4.4

 

AMENDED AND RESTATED INVESTOR
RIGHTS AGREEMENT

 

THIS AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT (this “Agreement”) made as of the 5th day of February 2016, by and among Regentis
Biomaterials Ltd., a company organized under the laws of the State of Israel, Israeli Company No. 513585240, located at 12
Ha’ilan street, Northern Industrial Zone, P.O.B 260, Or Akiva 30600, Israel(the “Company”), the individuals
and entities identified in Schedule 1 attached hereto (collectively, the “Series A Preferred
Holders”), the individuals and entities identified in Schedule 2 attached hereto ( the “Series B
Preferred Holders”); the individuals and entities identified in Schedule 3 attached hereto (collectively,
the “Series C Preferred Holders”), the individuals and entities identified in Schedule 4 attached
hereto ( the “Series D Preferred Holders” and together with the Series A Preferred Holders and the Series B
Preferred, Series C Preferred the “Preferred Holders”); The Company, the Series A Preferred Holders Series B
Preferred Holders the Series C Preferred Holders and the Series D Preferred Holders are referred to collectively herein as the
“Parties”, and each one separately as a “Party”.

 

RECITALS

 

WHEREAS, the Series A Preferred Holders, the
Series B Preferred Holders and the Series C Preferred Holders are the holders of all of the issued and outstanding shares of Series A
Preferred Shares Series B Preferred Shares and Series C Preferred Shares of the Company, par value NIS 0.01 each (the “Series
A Preferred”, “Series B Preferred” and “Series C Preferred” respectively); and

 

WHEREAS, pursuant to that certain
Series D Preferred Share Purchase Agreement with the Company dated as of the date hereof (the “Series D Purchase Agreement”),
the Series D- 1Preferred Holders and the Series D-2 Preferred Holders named on Schedules 4 are the holders of all of the issued and outstanding
shares of Series D-1Preferred Shares and the Series D-2 Preferred Shares of the Company, par value NIS 0.01 each (collectively the “Series
D Preferred” and together with the Series A Preferred, the Series B Preferred and the Series C Preferred, the “Preferred
Shares”); and

 

WHEREAS, to induce the Series
D Preferred Holders to enter into the Series D Purchase Agreement, the Company has agreed to grant to the Series D Preferred Holders certain
rights, as set forth herein; and

 

NOW THEREFORE, in consideration
of the mutual promises and covenants hereinafter set forth, the Parties agree as follows:

 

	1.	Definitions.

 

		1.1.	“Amended Articles” means the 6thAmended
and Restated Articles of Association of the Company as adopted pursuant to the Series D Purchase Agreement.

 

		1.2.	“IPO” means the initial public offering of the Company’s ordinary shares.

 

		1.3.	“register,” “registered,” and “registration”
refer to a registration effected by preparing and filing a registration statement in compliance with the U.S. Securities Act of 1933,
as amended, (the “Securities Act”), or the comparable laws of another jurisdiction, and the declaration or ordering
of effectiveness of such registration statement.

 

     

     

    

 

		1.4.	“Registrable Securities” means: (i) any Ordinary A shares of the Company issued
upon conversion of any Preferred Shares or issuable upon conversion of any Preferred Shares; (ii) all Ordinary A Shares that the Preferred
Holders may hereafter purchase or receive pursuant to their preemptive rights, rights of first refusal, anti dilution rights and otherwise,
and all Ordinary A Shares issued on conversion or exercise of other securities so purchased, including upon conversion of the Preferred
Shares, and (iii) any Ordinary A Shares of the Company issued as (or issuable upon the conversion or exercise of any warrant, right or
other security which is issued as) a dividend, bonus shares or other distribution with respect to, or in exchange for or in replacement
of, any shares described in clauses (i) through (iii) of this subsection 1.4.

 

		1.5.	“Holder” means any person owning of record Registrable Securities that have
not been sold to the public or pursuant to Rule 144 promulgated under the Securities Act or any permitted assignee of record of such Registrable
Securities to whom rights have been duly assigned in accordance with this Agreement.

 

		1.6.	“Form F-3” means such form under the Securities Act as is in effect on the date
hereof or any successor registration form under the Securities Act subsequently adopted by the SEC which permits inclusion or incorporation
of substantial information by reference to other documents filed by the Company with the SEC, or comparable form under the laws of another
jurisdiction.

 

		1.7.	“SEC” or “Commission” means the U.S. Securities and
Exchange Commission, or comparable securities authority of another jurisdiction.

 

	2.	Demand Registration.

 

		2.1.	Request by Holders. At anytime following the lapse of nine (9) months from the closing of the IPO,
if the Company receives a written request from Holders of a majority of the Registrable Securities (the “Initiating Holders”)
that the Company file a registration statement under the Securities Act covering the registration of Registrable Securities pursuant to
this Section 2 (the “Demand”), then the Company shall, within fourteen (14) days of the receipt of such written request,
give written notice of such request (“Request Notice”) to all Holders, and each Holder who is not an Initiating Holder
shall have twenty (20) days after receipt of the Request
Notice to notify the Company in writing of any Registrable Securities that they wish to be registered and included in such registration
(the “Response Notice”)and the Company shall then use its best efforts to effect, as soon as practicable, the registration
under the Securities Act of all Registrable Securities that Holders request to be registered and included in such registration pursuant
to the Response Notices it receives within the time stated above, subject only to the limitations of this Section 2, and provided that
the Company shall not be required to effect such registration unless the estimated aggregate offering price of all Registrable Securities
requested to be so registered is at least $2,000,000.

 

		2.2.	Underwriting. If the Initiating Holders intend to distribute the Registrable Securities covered
by their request by means of an underwriting, then they shall so advise the Company as a part of their request made pursuant to this Section
2 and the Company shall include such information in the Request Notice. In such event, the right of any Holder to include his Registrable
Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of
such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their
securities through such underwriting shall enter into an underwriting agreement in customary form with the managing underwriter or underwriters
selected for such underwriting by the Holders of a majority of the Registrable Securities being registered and reasonably acceptable to
the Company.

 

		2.3.	Priority. Notwithstanding any other provision of this Section 2, if the underwriter(s) advise(s)
the Company in writing that marketing factors require a limitation of the number of securities to be underwritten, then the Company shall
so advise all Holders of Registrable Securities which would otherwise be registered and underwritten pursuant hereto, and the number of
Registrable Securities that may be included in the underwriting shall be reduced as required by the underwriter(s) and allocated first,
to each of the Holders of Registrable Securities who requested inclusion of their Registrable Securities in such registration statement
on a pro rata basis based on the total number of Registrable Securities then held by each such Holder, and second, to any other
securities of the Company offered for sale; provided, however, that all shares that are not Registrable Securities and are
held by any other person, including, without limitation, any person who is an employee, officer or director of the Company (or any subsidiary
of the Company) shall first be excluded from such registration and underwriting before any Registrable Securities are so excluded.

 

    2

     

    

 

		2.4.	Withdrawal.

 

		2.4.1.	If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom
by written notice to the Company and the underwriter(s), delivered at least ten (10) business days prior to the effective date of the
registration statement. Any Registrable Securities excluded or withdrawn from such underwriting shall be excluded and withdrawn from the
registration.

 

		2.4.2.	The Initiating Holder may withdraw its request for a Demand Registration at any time and, it shall not
be deemed to have exhausted any rights to make Demand Registrations in the future, unless a registration statement has been filed with
the Securities and Exchange Commission, provided that such Initiating Holder reimburses the Company for all of its expenses incurred in
connection with such Demand Registration, if such registration has in fact been cancelled; provided, further, however, that such reimbursement
shall not be required if (i) at the time of such withdrawal, the Initiating Holder has learned of a material adverse change in the condition,
business, or prospects of the Company from that known to the Initiating Holder at the time of its request and such material adverse change
is reasonably likely to materially adversely affect the expected success of the required registration, (ii) such material change existed
at the time of notice submitted under Section 2.1 and the Company should have disclosed such information at such
time in accordance with its obligations under applicable law and (iii) the Initiating Holder has withdrawn the request with reasonable
promptness following disclosure by the Company of such material adverse change.

 

		2.5.	Deferral. Notwithstanding the foregoing, if within ten (10) days of receiving the Demand, as the
case may be, under this section 2, the Company shall furnish to the Holders a certificate signed by the chief executive officer or president
of the Company, stating that, in the good faith judgment of the Board of Directors of the Company (“Board”), it would
be seriously detrimental to the Company for such registration to be filed and it is therefore essential to defer the filing of such registration,
the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of the request and
not more than one time in any 12 month period.

 

		2.6.	Maximum Number of Demand Registrations. The Company shall be obligated to effect no more than two
(2) Demands pursuant to this Section 2 and the Company shall not be required to effect any registration under this Section 2 within a
period of one hundred and eighty (180) days following the effective date of a previous registration under this Section 2.

 

		2.7.	Expenses. All expenses incurred in connection with any registration pursuant to this Section 2,
including without limitation all federal and “blue sky” registration, filing and qualification fees, printer’s and accounting
fees, and fees and disbursements of counsel for the Company and one counsel for the Holders, shall be borne by the Company. Each Holder
participating in a registration pursuant to this Section 2 shall bear such Holder’s proportionate share (based on the total number
of shares sold in such registration other than for the account of the Company) of all discounts, commissions or other amounts payable
to underwriter(s) or brokers, in connection with such offering by the Holders. Notwithstanding the above, each Holder shall bear all the
expenses (including legal fees) incurred in connection with any registration requested by such Holder under Section 2, in the event that
the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered
in such said registration unless the Holders agree to forfeit their right to one registration pursuant to Section 2, provided,
however, that if prior to the time of such withdrawal, the Holders (i) have learned of a material adverse change in the condition,
business, or prospects of the Company that was not known to the Holders at the time of their request and (ii) have withdrawn the request
with reasonable promptness following disclosure by the Company of such material adverse change, then the Holders shall not be required
to pay any of such expenses and shall not forfeit their rights pursuant to Section 2.

 

		2.8.	In the event that the Initiating Holders request to effect a registration under this Section and the Company
decides to join and register any of its securities thereunder, such registration shall be regarded as Incidental (“Piggyback”)
Registration under Section 3 and not a Demand Registration under Section 2.

 

    3

     

    

 

	3.	Piggyback Registrations.

 

		3.1.	The Company shall notify all Holders of Registrable Securities in writing at least thirty (30) days prior
to filing any registration statement under the Securities Act for purposes of effecting a public offering of securities of the Company
(excluding the registration statement relating to the IPO and registration statements relating to any registration under Section 2 or
4 of this Agreement or to any employee benefit plan or a corporate reorganization) and will afford each such Holder an opportunity to
include in such registration statement all or any part of the Registrable Securities then held by such Holder. Each Holder desiring to
include in any such registration statement all or any part of the Registrable Securities held by such Holder shall within twenty (20)
days after receipt of the above-described notice from the Company, so notify the Company in writing, and in such notice shall inform the
Company of the number of Registrable Securities such Holder wishes to include in such registration statement. If a Holder decides not
to include all of its Registrable Securities in any registration statement thereafter filed by the Company, such Holder shall nevertheless
continue to have the right to include any Registrable Securities in any subsequent registration statement or registration statements as
may be filed by the Company with respect to offerings of its securities, all upon the terms and conditions set forth herein.

 

		3.2.	Underwriting. If a registration statement under which the Company gives notice under this Section
3 is for an underwritten offering, then the Company shall so advise the Holders of Registrable Securities. In such event, the right of
any such Holder’s Registrable Securities to be included in a registration pursuant to this Section 3 shall be conditioned upon such
Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting
to the extent provided herein. All Holders proposing to distribute their Registrable Securities through such underwriting shall enter
into an underwriting agreement in customary form with the managing underwriter or underwriters selected for such underwriting.

 

		3.3.	Priority. Notwithstanding any other provision of this Agreement, if the managing underwriter(s)
determine(s) in good faith that marketing factors require a limitation of the number of shares to be underwritten, then the managing underwriter(s)
may exclude or reduce shares from the registration and the underwriting, and the number of shares that may be included in the registration
and the underwriting shall be allocated in the same order as for a Demand Registration under Section 2.3 above, save that the shares to
be included in the registration statement by the Company shall take precedence over all other Registrable Securities.

 

		3.4.	Withdrawal. If any Holder disapproves of the terms of any such underwriting, such Holder may elect
to withdraw therefrom by written notice to the Company and the underwriter(s), delivered at least ten (10) business days prior to the
effective date of the registration statement. Any Registrable Securities excluded or withdrawn from such underwriting shall be excluded
and withdrawn from the registration.

 

		3.5.	Expenses. All expenses incurred in connection with a registration pursuant to this Section 3 (excluding
underwriters’ and brokers’ discounts and commissions relating to shares sold by the Holders), including, without limitation
all federal and “blue sky” registration, filing and qualification fees, printers’ and accounting fees, and fees and
disbursements of counsel for the Company and one counsel for the Holders, shall
be borne by the Company. Each Holder participating in a registration pursuant to this Section 3 shall bear such Holder’s proportionate
share (based on the total number of shares sold in such registration other than for the account of the Company) of all discounts, commissions
or other amounts payable to underwriter(s) or brokers, in connection with such offering by the Holders.

 

		3.6.	Termination. The Company shall have the right to terminate or withdraw any registration initiated
by it under this Section 3 prior to the effectiveness of such registration, regardless of whether any holder of Registrable Securities
has elected to include securities in such registration. If the Company decides to so terminate or withdraw any such registration, it shall
provide prompt written notice thereof to all Holders who had requested inclusion of their Registrable Securities in such registration.

 

		3.7.	Not Demand Registration. Registration pursuant to this Section 3 shall not be deemed to be a Demand
as described in Section 2 above.

 

		3.8.	Number of Piggyback Registrations. Except as otherwise provided herein, there shall be no limit
on the number of times that a Holder may request registration of Registrable Securities under this Section 3.

 

    4

     

    

 

	4.	Form F-3 Registration.

 

		4.1.	Following six (6) months after the IPO, and subject to Sections 4.1.1 – 4.1.3 below of this Section
4.1, if the Company shall receive from the Initiating Holders a written request or requests that the Company effect a registration on
Form F-3 and any related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder
or Holders, then the Company will promptly give written notice of the proposed registration and the Holder’s or Holders’ request
therefore, and any related qualification or compliance, to all other Holders of Registrable Securities and as soon as practicable, effect
such registration and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution
of all or such portion of such Holders or Holders’ Registrable Securities as are specified in such request, together with all or
such portion of the Registrable Securities of any other Holder or Holders joining in such request as are specified in a written request
given within twenty (20) days after the Company provides the notice contemplated above; provided, however, that the Company
shall not be obligated to effect any such registration, qualification or compliance pursuant to this Section 4:

 

		4.1.1.	if Form F-3 is not available for such offering by the Holders;

 

		4.1.2.	if the Holders, together with the holders of any other securities of the Company entitled to inclusion
in such registration, propose to sell Registrable Securities and such other securities (if any) at an aggregate price to the public of
less than $1,000,000;

 

		4.1.3.	if the Company has, within the six (6) month period preceding the date of such request, already effected
a registration on Form F-3 under the Securities Act other than a registration from which the Registrable Securities of Holders have been
excluded (with respect to all or any portion of the Registrable Securities the Holders requested be included in such registration).

 

		4.2.	Expenses. The Company shall pay all expenses incurred in connection with each registration requested
pursuant to this Section 4 (excluding underwriters’ or brokers’ discounts and commissions relating to shares sold by the Holders),
including without limitation federal and “blue sky” registration, filing and qualification fees, printers’ and accounting
fees, and fees and disbursements of counsel for the Company and one counsel for the Holders. Each Holder participating in a registration
pursuant to this Section 4 shall bear such Holder’s proportionate share (based on the total number of shares sold in such registration
other than for the account of the Company) of all discounts, commissions or other amounts payable to underwriter(s) or brokers, in connection
with such offering by the Holders.

 

		4.3.	Deferral. Notwithstanding the foregoing, if the Company shall furnish to Holders requesting the
filing of a registration statement pursuant to this Section 4, a certificate signed by the president or chief executive officer of the
Company stating that in the good faith judgment of the Board, it would be materially detrimental to the Company and its shareholders for
such registration statement to be filed, then the Company shall have the right to defer such filing for a period of not more than ninety
(90) days after receipt of the request of the initiating Holders; provided, however, that the Company may not utilize this
right more than once in any twelve (12) month period.

 

		4.4.	Not Demand Registration. Form F-3 registrations shall not be deemed to be “demand registrations”
as described in Section 2 above.

 

		4.5.	Number of F-3 Registrations. Except as otherwise provided herein, there shall be no limit on the
number of times that a Holder may request registration of Registrable Securities under this Section 4.

 

    5

     

    

 

	5.	Limitations; Blackout Periods

 

		5.1.	Notwithstanding Sections 2 and 3 above, the Company shall not be required to effect any registration:
(i) within one hundred and eighty (180) days after the effective date of registration effected pursuant to Section 2 or ninety (90) days
after the effective date of registration effected pursuant to Section 3 or Section 4; or (ii) during the pending period of any Demand
Blackout Period (as hereinafter defined).

 

		5.2.	If the Company determines in good faith that the registration and distribution of Registrable Securities
(or the use of a registration statement or related prospectus) would interfere with any pending financing, acquisition, corporate reorganization
or any other material corporate development involving the Company (or would require premature disclosure thereof), and promptly gives
the Holders written notice of such determination following their request to register any Registrable Securities, the Company shall be
entitled to postpone (but not more than once in any twelve (12) month period) the filing of the registration statement otherwise required
to be prepared and filed by the Company pursuant to Sections 2 or 3 for a reasonable period of time, but not to exceed 90 days
(a “Demand Blackout Period”). The Company shall promptly notify the Shareholders of the expiration or earlier termination
of any Demand Blackout Period. In the event of a Demand Blackout Period, the Company shall undertake to extend the effectiveness of any
then current registration statement on Form F-3 beyond the anticipated nine (9) month
period or any then current registration statement on other forms (including F-1) beyond the anticipated six (6) month period for the
respective periods of such Demand Blackout Period.

 

	6.	Obligations of the Company.

 

Whenever required to effect the registration
of any Registrable Securities under this Agreement, the Company shall, as expeditiously as reasonably possible:

 

		6.1.	Registration Statement. Prepare and file with the SEC a registration statement with respect to
such Registrable Securities and use its best efforts to cause such registration statement to become effective for at least 6 months (and
in the case of registration on Form F-3, for at least 12 months), or if earlier, until the distribution of Registrable Securities described
in the registration statement has been completed.

 

		6.2.	Amendments and Supplements. Prepare and file with the SEC such amendments and supplements to such
registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions
of the Securities Act with respect to the disposition of all securities covered by such registration statement.

 

		6.3.	Prospectuses. Furnish to the Holders such number of copies of a prospectus, including a preliminary
prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order
to facilitate the disposition of the Registrable Securities owned by them that are included in such registration.

 

		6.4.	Blue Sky. Use its best efforts to register and qualify the securities covered by such registration
statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided
that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general
consent to service of process in any such states or jurisdictions.

 

		6.5.	Underwriting. In the event of any underwritten public offering, enter into and perform its obligations
under an underwriting agreement in usual and customary form, with the managing underwriter(s) of such offering. Each Holder participating
in such underwriting shall also enter into and perform its obligations under such an agreement.

 

		6.6.	Notification. Notify each Holder of Registrable Securities covered by such registration statement
at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a
result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material
fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the
light of the circumstances under which they were made.

 

    6

     

    

 

		6.7.	Opinion and Comfort Letter. Furnish, at the request of any Holder requesting registration of Registrable
Securities, except for a request for registration pursuant to Section 4.1 hereof, on the date that such Registrable Securities are delivered
to the underwriter(s) for sale, if such securities are being sold through underwriters, or, if such securities are not being sold through
underwriters, on the date that the registration statement
with respect to such securities becomes effective, (i) an opinion, dated as of such date, of the counsel representing the Company for
the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering and
reasonably satisfactory to a majority in interest of the Holders requesting registration, addressed to the underwriters, if any, and to
the Holders requesting registration of Registrable Securities and (ii) a “comfort” letter dated as of such date, from the
independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public
accountants to underwriters in an underwritten public offering and reasonably satisfactory to a majority in interest of the Holders requesting
registration, addressed to the underwriters, if any, and to the Holders requesting registration of Registrable Securities.

 

		6.8.	Furnish Information. It shall be a condition precedent to the obligations of the Company to take
any action pursuant to Sections 2, 3 or 4 that the selling Holders shall furnish to the Company such information regarding themselves,
the Registrable Securities held by them, and the intended method of disposition of such securities as shall be reasonably required to
timely effect the registration of their Registrable Securities.

 

		6.9.	Rule 144: With a view to making available the benefits of Rule 144 under the Securities Act (or
similar rule then in effect) available to the holders of Registrable Securities, after the initial public offering of any securities of
the Company over the counter or on any recognized stock exchange or quotation system, the Company shall:

 

		6.9.1.	Make and keep available adequate current public information with respect to the Company within the meaning
of Rule 144 under the Securities Act (or similar rule then in effect);

 

		6.9.2.	Furnish to any holder of Registrable Securities forthwith upon request (i) a
written statement by the Company as to its compliance with the informational requirements of Rule 144 or similar rule then in effect)
or (ii) a copy of the most recent annual or quarterly report of the Company; and

 

		6.9.3.	Comply with all other necessary filings and other requirements so as to enable the holders of Registrable
Securities to sell Registrable Securities under Rule 144 under the Securities Act (or similar rule then in effect).

 

		6.10.	Terminationof the Company’s Obligations. The right of any Holder to request registration
or inclusion in any registration under this Agreement shall terminate on the fifth anniversary of the Company’s IPO.

 

		6.11.	Limitations on Subsequent Registration Rights. The Company shall not, without the prior written
consent of the majority in interest of the holders of the Registrable Securities (for as long as each hold Registrable Securities),
enter into any agreement with any holder or prospective holder of any securities of the Company which would allow such holder or prospective
holder to include such securities in any registration filed under this Agreement.

 

    7

     

    

 

	7.	Indemnification.

 

In the event any
Registrable Securities are included in a registration statement under Sections 2, 3 or 4:

 

		7.1.	By the Company. To the extent permitted by law, the Company will indemnify and hold harmless each
Holder, the partners, officers and directors of each Holder, any underwriter for such Holder and each person, if any, who controls such
Holder or underwriter within the meaning of the Securities Act or the Securities Exchange Act of 1934, as amended (the “1934
Act”), against any losses, claims, damages, liabilities, costs or expenses (collectively “Losses”) to which
they may become subject under the Securities Act, the 1934 Act or other federal or state law, insofar as such Losses (or actions in respect
thereof) arise out of or are based upon any of the following (collectively a “Violation”):

 

		7.1.1.	any untrue statement or alleged untrue statement of a material fact contained in such registration statement,
including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto;

 

		7.1.2.	the omission or alleged omission to state therein a material fact required to be stated therein, or necessary
to make the statements therein not misleading, or

 

		7.1.3.	any violation or alleged violation by the Company of the Securities Act, the 1934 Act, any federal or
state securities law or any rule or regulation promulgated under the Securities Act, the 1934 Act or any federal or state securities law
in connection with the offering covered by such registration statement;

 

and the Company will reimburse each
such Holder, partner, officer or director, underwriter or controlling person for any legal or other expenses reasonably incurred by them,
as incurred, in connection with investigating or defending any such Losses or action; provided, further, that this indemnity
shall not be deemed to relieve any underwriter of any of its due diligence obligations; provided, however, that the indemnity
agreement contained in this subsection 7.1 shall not apply to amounts paid in settlement of any such Losses or action if such settlement
is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in
any such case for any such Losses or action to the extent (and only to the extent) that it arises out of or is based upon a Violation
which occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such registration
by such Holder, partner, officer, director, underwriter or controlling person of such Holder.

 

		7.2.	By Selling Holders. To the extent permitted by law, each selling Holder will severally indemnify
and hold harmless the Company, each of its directors, each of its officers who have signed the registration statement, each person, if
any, who controls the Company within the meaning of the Securities Act, and any other Holder selling securities under such registration
statement or any of such other Holder’s partners, directors or officers or any person who controls such Holder within the meaning
of the Securities Act or the 1934 Act, against any Losses to which the Company or any such director, officer, controlling person, or other
such Holder, partner or director, officer or controlling person of such other Holder may become subject under
the Securities Act, the 1934 Act or other federal or state law, insofar as such Losses (or actions in respect thereto) arise out of or
are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity
with material written information furnished by such Holder expressly for use in connection with such registration; and each such Holder
will reimburse any legal or other expenses reasonably incurred by the Company or any such director, officer, controlling person, or other
Holder, partner, officer, director or controlling person of such other Holder in connection with investigating or defending any such Losses
or action: provided, however, that the indemnity agreement contained in this subsection 7.2 shall not apply to amounts paid
in settlement of any such Losses or action if such settlement is effected without the consent of the Holder, which consent shall not be
unreasonably withheld; and provided, further, that the total amounts payable in indemnity by a Holder under this Section
7 in respect of any Violation shall not exceed the net proceeds received by such Holder in the registered offering in connection with
which such Violation arises.

 

		7.3.	Notice. Promptly after receipt by an indemnified party under this Section 7 of notice of the commencement
of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any
indemnifying party under this Section 7, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying
party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying
party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however,
that an indemnified party shall have the right to retain its own counsel, with the fees and expenses to be paid by the indemnifying party,
if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or
potential conflict of interests between such indemnified party and any other party represented by such counsel in such proceeding. The
failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action shall not
relieve such indemnifying party of liability to the indemnified party under this Section 7, unless and to the extent the indemnifying
party is actually prejudiced as a result thereof, but the omission so to deliver written notice to the indemnified party in any event
will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 7.

 

    8

     

    

 

		7.4.	Defect Eliminated in Final Prospectus. The foregoing indemnity agreements of the Company and Holders
are subject to the condition that, insofar as they relate to any Violation made in a preliminary prospectus but eliminated or remedied
in the amended prospectus on file with the SEC at the time the registration statement in question becomes effective or the amended prospectus
filed with the SEC pursuant to SEC Rule 424(b) (the “Final Prospectus”), such indemnity agreements shall not inure
to the benefit of indemnified party if a copy of the Final Prospectus was timely furnished to suchindemnified party even if and the Final
Prospectus was not furnished to the person asserting the loss, liability, claim or damage at or prior to the time such action is required
by the Securities Act.

 

		7.5.	Contribution. In order to provide for just and equitable contribution to joint liability
                                                                under the Securities Act in any case in which either (i) any Holder, the partners, officers and directors of any such Holder, any
                                                                underwriter for any such Holder or any controlling person of any such Holder, makes a claim for indemnification pursuant to this
                                                                Section 7 but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the
                                                                expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case
                                                                notwithstanding the fact that this Section 7 provides for indemnification in such case, or (ii) contribution under the Securities
                                                                Act may be required on the part of any such selling Holder or any such controlling person in circumstances for which indemnification
                                                                is provided under this Section 7; then, and in each such case, the Company and such Holder will contribute to the aggregate Losses
                                                                to which they may be subject (after contribution from others) in such proportion as is appropriate to reflect the relative fault of
                                                                the Holder on the one hand and the Company and other selling Holders on the other, in connection with the matters that resulted in
                                                                such Losses, as well as any other relevant equitable considerations. The relative fault of the Holder, the Company and other selling
                                                                Holders shall be determined by a court of law by reference to, among other things, whether the untrue or alleged untrue statement of
                                                                a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Holder, the
                                                                Company or the other selling Holders and the parties’ relative intent, knowledge, access to information and opportunity to
                                                                correct or prevent such statement or omission; provided, however, that, in any such case: (A) no such Holder will be
                                                                required to contribute any amount in excess of the net proceeds to the Holder from all such Registrable Securities offered and sold
                                                                by such Holder pursuant to such registration statement; and (B) no person or entity guilty of fraudulent misrepresentation (within
                                                                the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person or entity who was not guilty of
                                                                such fraudulent misrepresentation.

 

	8.	Lock-Up

 

In any underwritten registration
of the Company’s shares, all holders of Registrable Securities and other holders of the Company’s securities agree that
any sales of Registrable Securities or other securities of the Company may be subject to a “lock- up” period restricting
such sales for up to one hundred and eighty (180) days. In addition, all holders who participate in any other registration of
securities by the Company will agree to abide by customary “lock-up” periods of up to one hundred and eighty (180) days
if required by the underwriter in such registration. Notwithstanding the above, the obligations of the holders of Registrable
Securities shall be contingent upon all executive officers and directors of the Company and all holders of greater than 1% (one
percent) of the Company’s securitiesentering into similar lock-up agreements or otherwise being bound by substantially
similar lockup arrangements. Any discretionary waiver or termination of the restrictions contained in any such agreement by the
Company or the underwriter shall first apply to the holders of Registrable Securities, who shall have preference over all other
holders of the Company’s securities to register and sell the shares to be registered within such waiver or termination of
restrictions in accordance with the terms of priority set forth herein. In addition, no Holder may participate in any underwritten
registration hereunder unless such person (a) agrees to sell such person’s securities on the basis provided in any customary
underwriting agreement and (b) provides any relevant information and completes and executes all questionnaires, powers of attorney,
indemnities, underwriting agreements and other documents required under the terms of such underwriting arrangements; provided that
such underwriting arrangements shall not provide for indemnification or contribution obligations on the part of the Holders greater
than the obligations set forth in Section 7 above.

 

	9.	Parties Undertakings

 

		9.1.	Assignment of Registration Rights. The registration rights of any Holder under this Agreement may
be assigned to any person or entity to whom such Holder lawfully transfers its Registrable Securities then outstanding, provided that
such transfer is not in violation of the terms of the Amended Articles; provided, however, that no party may assign any
of the foregoing rights unless the Company is given written notice by the assigning party at the time of such assignment stating the name
and address of the assignee and identifying the securities of the Company as to which the rights in question are being assigned; and provided
further, that any such assignee shall receive such assigned rights subject to such assignee’s agreement in writing to be bound
by all the terms and conditions of this Agreement.

 

		9.2.	Registration Outside the U.S. The provisions of Sections 1 to 9 hereof shall apply also, mutatis
mutandis, to any registration of shares of the Company in any jurisdiction other than the U.S.

 

    9

     

    

 

	10.	Information and Inspection Rights

 

		10.1.	Until the consummation of the IPO, the Company shall deliver to each holder of Preferred Shares (in this
Section 10 only, an “Eligible Shareholder”):

 

		(i)	within 7 days from the day they are delivered to the Company, but in any event within 90 (ninety) days
after the end of each fiscal year of the Company, financial statements of the Company for such year including a consolidated balance sheet
of the Company as of the end of such year, and statements of income and statements of cash flow of the Company for such year, setting
forth in each case in comparative form the figures for the previous fiscal year, all in reasonable detail, United States dollar- denominated,
prepared in accordance with US GAAP audited by a firm of Independent Certified Public Accountants in the State of Israel who are members
of the Israeli Institute of Certified Public Accountants and affiliated with one of the “big four” U.S. accounting firms (“Independent
Accounting Firm”), accompanied by an opinion of such firm which opinion shall state that such balance sheet and statements of
income and cash flow have been prepared in accordance with GAAP applied on a basis consistent with that of the preceding fiscal year,
and present fairly and accurately the financial position of the Company as of their date; and

 

		(ii)	within 7 days from the day they are delivered to the Company, but in any event within 45 (forty five)
days after the end of each fiscal quarter of the Company, unaudited but reviewed financial statements of the Company as of the end of such quarter,
containing an unaudited consolidated balance sheet of the Company as at the end of each such period and unaudited consolidated statements
of (i) income and (ii) cash flow of the Company for such period and, in the case of the first, second and third quarterly periods, for
the period from the beginning of the current fiscal year to the end of such quarterly period, setting forth in each case in comparative
form the figures for the corresponding period of the previous fiscal year, all in reasonable detail, United States dollar- denominated
and certified, by the chief financial officer (or if none, by the chief executive officer) of the Company (the “CFO”),
that such financial statements were prepared in accordance with US GAAP applied on a basis consistent with that of preceding periods and,
except as otherwise stated therein, fairly present the financial position of the Company as of their date subject to footnotes in accordance
with customary format and changes resulting from year-end audit adjustments, all reviewed by an Independent Accounting Firm.

 

Until the consummation of the IPO,
the Company shall deliver to each holder of Preferred Shares who has a right to appoint a director to the Company’s Board:

 

		(a)	as soon as practicable, but in any event within fifteen (15) days after the end of each month, a report
in a form agreed from time to time by the Board, which report shall include a business update and review, and unaudited consolidated balance
sheet and unaudited estimated consolidated statements of income and statements of cash flow of the Company (including, opening cash, income,
expenses and closing cash) as at the end of such month, representing the actual results against the annual operating plan and budget;

 

		(b)	no later than thirty (30) days prior to the beginning of each calendar year, the including Detailed Financialprojections;
and

 

		(c)	with reasonable promptness, such other information as shall be reasonably requested by such shareholder.

 

All the financial
reports referred to above shall be denominated in Dollars and prepared in the English language.

 

		10.2.	At any reasonable time and from time to time, upon reasonable notice, the Company shall permit representatives
of each Eligible Shareholder which has the right to appoint a director full and free access to any of the properties of the Company, to
examine the facilities, records and books of account of the Company, to inspect any of the properties or assets of the Company and visit
the properties of the Company and to discuss the affairs, finances and accounts of the Company with any of its officers, and senior personnel
of the Company, all subject to the confidentiality undertakings contained in Section 12 below.

 

    10

     

    

 

		10.3.	This Section 10 shall not be in limitation of any rights which the Eligible Shareholder or the directors
designated by the Eligible Shareholder may have under applicable law.

 

		10.4.	The Company will maintain and cause each of its Subsidiaries to maintain a system of accounting
                                                                 established and administered in accordance with GAAP consistently applied, and will set aside on its books and cause each of its operating Subsidiaries to set aside
on its books all such proper reserves as shall be required by GAAP. For purposes of this Section 10.4, “Subsidiary”
means any corporation or entity at least a majority of whose voting securities are at the time owned by the Company, or by one or more
Subsidiaries, or by the Company and one or more Subsidiaries.

 

		10.5.	CFC and PFIC.

 

The Company
commits that immediately after the Closing (as defined in the SPA), the Company will not be a “Controlled Foreign Corporation”
(“CFC”) as defined in the U.S. Internal Revenue Code of 1986, as amended (or any successor thereto) with respect to
the Shares held by the Preferred Shareholders. In the event that the Company is determined by counsel or accountants to the Preferred
Shareholders to be a CFC with respect to the Shares held by the Preferred Shareholders, the Company agrees to use commercially reasonable
efforts to avoid generating “subpart F income,” as such term is defined in Section 952 of the Code.

 

The Company
is not, and will not be at any time during the calendar year in which the Closing occurs, a “passive foreign investment company”
within the meaning of Section 1297 of the Internal Revenue Code of 1986, as amended (or any successor thereto). The Company shall use
its best efforts to avoid being a “passive foreign investment company” within the meaning of Section 1297 of the Internal
Revenue Code of 1986, as amended (or any successor thereto). In connection with a “Qualified Electing Fund” election made
by the Preferred Shareholders pursuant to Section 1295 of the Internal Revenue Code of 1986 or a “Protective Statement” filed
by the Preferred Shareholders pursuant to Treasury Regulation Section 1.1295-3, as amended (or any successor thereto), the Company shall
provide annual financial information to the Preferred Shareholders, in the form provided by the Preferred Shareholders, as soon as reasonably
practicable following the end of each taxable year of the Preferred Shareholders (but in no event later than 90 days following the end
of each such taxable year), and shall provide the Preferred Shareholders with access to such other Company information as may be required
for purposes of filing U.S. federal income tax returns in connection with such Qualified Electing Fund election or Protective Statement.

 

The Company
shall use its best efforts to take such actions, including making an election to be treated as a corporation or refraining from making
an election to be treated as a partnership, as may be required to ensure that at all times the company is treated as corporation for United
States federal income tax purposes.

 

In the
event that the Preferred Shareholders’ interest in the Company is determined by counsel or accountants for the Preferred
Shareholders to be subject to the reporting requirements of either or both of Sections 6038 and 6038B the Company agrees, upon a
request from the Preferred Shareholders, to provide such information to the Preferred Shareholders as may be reasonably necessary to
fulfill the Preferred Shareholders’ obligations thereunder.

 

    11

     

    

 

		11.	Company’s Additional Covenants

 

		11.1.	Confidentiality and Non-Competition Agreements. The Company and its subsidiaries
will not employ, or continue to employ, any person who will have access to material confidential information with respect to the Company
and its operations unless such person has executed and delivered a Confidentiality and Non-Competition Agreement to the satisfaction (as
to substance and form) of the Company’s Board of Directors and legal counsel.

 

		11.2.	Properties and Business Insurance. The Company and its subsidiaries shall maintain
insurance against such casualties and contingencies and of such types and in such amounts as is customary for companies similarly situated.

 

		11.3.	Restrictive Agreements Prohibited. The Company and its subsidiaries shall
not become a party to any agreement, which by its terms restricts the Company’s performance of this Agreement or the terms of its
Corporate Documents.

 

		11.4.	Compliance with Laws. The Company shall take all necessary actions to amend
the Company’s products in a way such products shall comply, and cause each subsidiary to comply, with all applicable laws, rules, regulations
and orders, noncompliance with which could have a material adverse effect on the Company.

 

		12.	Confidentiality

 

		12.1.	Each Preferred Holder agrees that any Confidential Information(as hereinafter defined
in Section 12.2)obtained from, or on behalf of, the Company will be used solely for the purpose of monitoring its investment in the Company,
and will not be used for any other purpose or disclosed to any person without the prior written consent of the Company (except to such
shareholder’s employees, officers, directors and agents on a need to know basis); provided, however, that in connection with
periodic reports of the holders of Preferred Shares to their shareholders or partners, such holders may, without first obtaining such
written consent, make general statements, not containing technical or other confidential information, regarding the nature and progress
of the Company’s business; and provided further, that such holders may provide summary information regarding the Company’s
financial information in their reports to their respective shareholders or partners, but may not annex to such reports the full financial
information to be provided hereunder by the Company; and provided further, however, that in the event that such holder is required
to annex financial information obtained pursuant hereto to such reports, such holder shall be entitled to annex such financial information
to such reports ; provided further, however, that in the event that a shareholder is required by law or regulation to annex financial
information obtained pursuant to Section 10 to such reports, such shareholder shall exert its reasonable efforts to avoid annexing such
financial information, in a manner consistent with applicable law and practice, but to the extent that its efforts are unsuccessful, such
shareholder shall be entitled to annex such financial information to such reports.

 

    12

     

    

 

	 	12.2.	For the purposes of this Agreement, “Confidential Information” shall have the following meaning: any scientific and/or technical and/or business information, including, inter alia, drawings and graphs, which will be furnished by the Company to the shareholders, their employees and/or their agents, including without limitation all information or reports furnished to any shareholder pursuant to Section 10 of this Agreement, but shall not include information (i) which is or becomes public knowledge through no fault of the receiving party; or (ii) which is known to the receiving party at the time of disclosure by the disclosing party, as evidenced by the receiving party’s written records; (iii) which is disclosed to the receiving party on a non-confidential basis by a third party having no obligation of secrecy to the disclosing party; (iv) information required to be disclosed by law, a governmental body, rule, regulation or judicial order, provided that prior notice of disclosure is given to the disclosing party; or (v) which is subsequently independently developed by or for the receiving party without use of Confidential Information.

 

	 	12.3.	This section 12 shall survive any termination of this Agreement.

 

		13.	Additional
Parties

  

Prior to transferring any Preferred
Shares (or any interest therein) to any person or entity, the transferor shall cause the prospective transferee to execute and deliver
to the Company an agreement to be bound by the terms of this Agreement (to the extent such transferee is not already a party hereto

 

		14.	Miscellaneous

 

	 	14.1.	Governing Law and Jurisdiction. All disputes arising under this Agreement or in connection with the transactions hereunder,including the validity, interpretation, performance, breach or termination thereof,shall be resolved between the parties in good faith.However, if these efforts fail, the dispute shall be exclusively referred to and finally resolved by arbitration administered by the Arbitration and Dispute Resolution Center (currently chaired by Adv. Dalia Rabin – the “Arbitration Center”) by a single arbitrator in accordance with the Rules of Arbitration of the Arbitration Center. The arbitration shall be held in Tel Aviv, Israel, in the English language. The arbitrator shall make a final and binding award in respect of any such dispute. The award shall not be subject to appeal before an arbitration panel or before any court of competent jurisdiction. This section constitutes an arbitration agreement between the parties in accordance with article 1 of the Arbitration Law, 5728-1968.

 

		14.2.	Successors and Assigns. Except as otherwise expressly provided herein, the
provisions hereof shall inure to the benefit of, and be binding upon, the successors, assignees, heirs, executors and administrators of
the parties hereto. No assignment of any rights or obligations pursuant to this Agreement may be made by a shareholder except with a transfer
of shares held by such shareholder in accordance with the Amended Articles.

 

		14.3.	Entire Agreement; Amendment and Waiver. This Agreement contains the entire understanding of the
                                                                                                           parties hereto with respect to the subject matter hereof and supersedes all other agreements between or among any of the parties
                                                                                                           with respect to the subject matter hereof. This agreement may be amended or terminated by the consent in writing of (i) the Company
                                                                                                           (ii) a two-third majority in interest of the holders of the Registrable Securities. However, when the amendment or termination
                                                                                                           relates to rights of a specific class of Shareholders the agreement may only be amended or terminated by the consent in writing by (i) the Company and (ii) a two-third
(66.67%) majority in interest of the holder of the specific class of Preferred Shares. Any of the holders of Preferred Shares may waive
any of its, his or her rights or the Company’s obligations hereunder without obtaining the consent of any other person.

 

    13

     

    

 

	 	14.4.	Notice. All notices or other communications provided for in this Agreement shall be in writing and shall be given in person, by registered mail (registered air mail if mailed internationally), by an overnight courier service which obtains a receipt to evidence delivery, or by facsimile transmission (provided that written confirmation of transmission is received), addressed as set forth below:

 

	 	Company	At the address set forth in the preface above;
	 	 	with a copy to (which does not constitute a service of process):
	 	 	Doron Tikotzky Kantor Gutman Cederboum & SRFF., Law Offices
	 	 	
    12 Abba Hillel Rd, Ramat Gan, 52506 

    Facsimile: 972-3- 613-3372

	 	 	
    Telephone: 972-3- 613-3371

    email: rcavallero@dtkgc.com

    Attention: Rachel Cavallero, Adv. 

	 	 	 
	 	Preferred Shareholders	At the addresses set forth in Schedule 1 and 2,
	 	 	with a copy with respect to Medica to (which does not constitute a service of process):
	 	 	with a copy with respect to Vitalife to (which does not constitute a service of process):

 

or such other address as any party may
designate to the other in accordance with the aforesaid procedure. All notices and other communications delivered in person or shall
be deemed to have been given on the date of actual delivery; those delivered by courier service shall be deemed to have been given one
business day after the date of dispatch; those given by facsimile transmission with confirmed transmission shall be deemed to have been
given on the date of transmittal (provided that such date is a business day in the country of receipt and if not, the next business day),
and all notices and other communications sent by registered mail shall be deemed given ten (10) days after posting.

 

		14.5.	Delays or Omissions. No delay or omission to exercise any right, power or
remedy, upon any breach or default under this Agreement, shall impair any such right, power or remedy of such holder nor shall it be construed
to be a waiver of any such breach or default, or an acquiescence therein, or of any similar breach or default thereafter occurring.

 

		14.6.	Waiver of Default. No waiver with respect to any breach or default in the
performance of any obligation under the terms of this Agreement shall be deemed to be a waiver with respect
to any subsequent breach or default, whether of similar or different nature. Any waiver, permit, consent or approval of any kind or character
on the part of any party hereunder of any breach or default under this Agreement, or any waiver on the part of any part of any provisions
or conditions of this Agreement shall be effective only if made in writing and signed by the party purporting to make the waiver and only
to the extent specifically set forth in such writing and only with respect to the party making the waiver. All remedies, either under
this Agreement or by virtue of law or otherwise afforded to any holder, shall be cumulative and not alternative.

 

    14

     

    

 

		14.7.	Rights; Severability. In case any provision of the Agreement shall be held
to be invalid, illegal or unenforceable by a court of competent jurisdiction, the validity, legality and enforceability of the remaining
provisions shall not in any way be affected or impaired thereby. The parties hereto shall be obliged to draw up an arrangement in accordance
with the meaning and the object of the invalid provision.

 

		14.8.	Further Instruments and Actions. The parties agree to execute such further
instruments and to take such further action as may reasonably be necessary to carry out the transactions contemplated by this Agreement.

 

		14.9.	Titles and Subtitles. The titles of the sections and subsections of this
Agreement are for convenience of reference only and are not to be considered in construing this Agreement.

 

		14.10.	Counterparts. This Agreement may be executed contemporaneously in one or
more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

		14.11.	Aggregation of Shares. All shares held or acquired by a Permitted Transferee
(as such term is defined in the Amended Articles) of a Holder shall be aggregated together with the shares held by the Holder for the
purpose of determining the availability of any rights under this Agreement.

 

[Remainder of Page Intentionally Left
Blank]

 

    15

     

    

 

IN WITNESS WHEREOF, the undersigned
have executed this Investor Rights Agreement as of the date set forth above.

 

Company:

 

	Regentis Biomaterials Ltd.	 

 

	By:		 
	Name: 		 
	Title:		 

 

[First Signature Page to the Investor Rights
Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, the parties
hereto have executed this Investors Rights Agreement as of the date first above written.

 

The Technological Incubator Founded by the Technion R&D Foundation
Ltd. 

 

	By:	 	 
	Name: 	 	 
	Title:	 	 

 

Technion Research and Development Foundation Ltd.

 

	By:		 
	Name: 		 
	Title:		 

 

[Second Signature Page to the Investor Rights
Agreement]

 

     

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Investors Rights Agreement as of the date first above written.

 

	Pro-Seed
	 
	By:	 	 
	Name:	 	 
	Title:	 	 
	 
	Shalom Hotbed SA
	 
	By:	 	 
	Name:	 	 
	Title:	 	 

 

[Third
Signature Page to the Investor Rights Agreement]

 

     

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Investors Rights Agreement as of the date first above written.

 

	Medica III Investments (International) L.P.	 	Medica III Investments (Israel) L.P.
	 	 	 
	By: Medica III Management L.P.	 	By: Medica III Management L.P.
	its general partner	 	its general partner
	 	 	 
	By: Medica III Management Co.	 	By: Medica III Management Co.
	its general partner	 	its general partner
	 	 	 
	By:		 	By:	   
	Name:  	Ehud Geller	 	Name:	Ehud Geller
	Title:	Director	 	Title:	Director
	 	 	 
	Medica III Investments (S.F.) L.P.	 	Medica III Investments (P.F.) L.P.
	 	 	 
	By: Medica III Management L.P.	 	By: Medica III Management L.P.
	its general partner	 	its general partner
	 	 	 
	By: Medica III Management Co.	 	By: Medica III Management Co.
	its general partner	 	its general partner
	 	 	 
	By:	 	 	By:	 
	Name:	Ehud Geller	 	Name:	Ehud Geller
	Title:	Director	 	Title:	Director
		 	 
	Medica III Investments (Israel) (B) L.P.	 	PoalimMedica III Investments L.P. 
	 	 	 
	By: Medica III Management L.P.	 	By: Medica III Management L.P.
	its general partner	 	its general partner
	 	 	 
	By: Medica III Management Co.	 	By: Medica III Management Co.
	its general partner	 	its general partner
	 	 	 
	By:	 	 	By:	 
	Name:	Ehud Geller	 	Name: 	Ehud Geller
	Title:	Director	 	Title:	Director

  

[Fourth
Signature Page to the Investor Rights Agreement]

 

     

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Investors Rights Agreement as of the date first above written.

 

	Vitalife Partners (Israel) L.P.	 	Vitalife Partners (DCM) L.P.
	 	 	 
	By:  Vitalife Partners Management L.P.,	 	By:  Vitalife Partners Management L.P.,
	            its General Partner	 	         its General Partner
	By:  Vitalife Life Sciences Ltd.,	 	By:  Vitalife Life Sciences Ltd.,
	            its General Partner	 	         its General Partner
	 	 	 
	By:	          	 	By:	           
	Name:	 	 	Name:	 
	Title:	 	 	Title:	 
	 	 	 
	Vitalife Partners (Overseas) L.P	 	SCP Vitalife Partners II, L.P.
	 	 	 
	By:  Vitalife Partners Management L.P.,	 	By:  SCP Vitalife II Associates, L.P.,
	            its General Partner	 	         its General Partner
	By:  Vitalife Life Sciences Ltd.,	 	By:  SCP Vitalife II GP, Ltd.,
	            its General Partner	 	          its General Partner
	 	 	 
	By:	 	 	By:	 
	Name:	 	 	Name:	 
	Title:	 	 	Title:	 
	 	 	 
	SCP Vitalife Partners (Israel) II, L.P.	 	Technion Research and Development Foundation Ltd.
	By:  SCP Vitalife II Associates, L.P.,	 	 
	          its General Partner	 	By:	 
	By:  SCP Vitalife II GP, Ltd.,	 	Name: 	 
	          its General Partner	 	Title:	 
	 	 	 	 
	By:	 	 	 
	Name:	 	 	 
	Title:	 	 	 

  

 

[Fifth
Signature Page to the Investor Rights Agreement]

 

     

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Investors Rights Agreement as of the date first above written.

  

	DSM Venturing B.V.
	 
	By:	     	 
	Name:	 	 
	Title:	 	 
	 	 
	Allegro S.àr.l
	 
	By:	 	 
	Name:	 	 
	Title:	 	 

 

     

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Investors Rights Agreement as of the date first above written.

 

	HaisThera Scientific Fund I, L.P.	 
	 	 
	By:	      	 
	Name:	 	 
	Title:	 	 

 

     

     

    

 

Schedule
1

 

List
of Series A Preferred Holders

 

Name and Address of Preferred A Holder

 

Shalom
Hotbed SA.

Le Patier-CH-1936, Verbier No.

 CH-621.3.006.775,
St. Maurice,

 Valais/Switzerland

 

Pro-Seed Venture Capital Fund Ltd.

85
Yehuda Halevy, Tel Aviv, Israel

 

Technion Research and Development Foundation
Ltd.

Technion City, Haifa 32000, Israel

 

Technological Incubator Founded by the Technion
R&D Foundation Ltd.

Matam-Advanced Technology Center

Building No. 30, POB 15054

Haifa 31905 Israel

 

Vitalife Partners (Israel) L.P.

32B Habarzel Street

Tel Aviv 69710

Israel

 

Vitalife Partners (D.C.M.) L.P.

32B Habarzel Street

Tel Aviv 69710

Israel

 

Vitalife Partners (Overseas) L.P.

32B Habarzel Street

Tel Aviv 69710

Israel

 

     

     

    

 

Schedule
2

 

List
of Series B Preferred Holders

 

	Name
of Preferred B Holder
	Address:
	Medica
    III Investments International L.P.	4
    HaSadnaot St., 1st floor,

    Herzliya
    46128.

    Israel

	Medica
    III Investments (S.F.) L.P.
	Medica
    III Investments (P.F.) L.P.
	Medica
    III Investments (Israel) L.P.
	Medica
    III Investments (Israel) (B) L.P.
	PoalimMedica
    III Investments L.P.

    (Collectively:
    “Medica”)

 

	Name
    of Preferred B Holder	Address:
	Vitalife
    Partners (Israel) L.P.	32B
    Habarzel Street

    Tel
    Aviv 69710

    Israel

	Vitalife
    Partners (D.C.M.) L.P.
	Vitalife
    Partners (Overseas) L.P.
	SCP
    Vitalife Partners II
	SCP
    Vitalife Partners (Israel) II
	(Collectively:
    “Vitalife”)

 

	Name
    of Preferred B Holder	Address:
	Technion
    Research and Development Foundation Ltd.	Technion
    City

    Haifa
    32000

    Israel

 

     

     

    

 

Schedule
3

 

List
of Series C Preferred Holders

 

	Name
    of Preferred C Holder	Address:
	DSM
    Venturing B.V.	1
    Het Overloon,

    6411
TE Heerlen,

The Netherlands

	(“DSM”)  

 

 

	Name
    of Preferred C Holder	Address:
	Medica
    III Investments International L.P.	4
    HaSadnaot St., 1st floor,

    Herzliya
    46128.

    Israel

	Medica
    III Investments (S.F.) L.P.
	Medica
    III Investments (P.F.) L.P.
	Medica
    III Investments (Israel) L.P.
	Medica
    III Investments (Israel) (B) L.P.
	PoalimMedica
    III Investments L.P.

    (Collectively:
    “Medica”)

 

	Name
    of Preferred C Holder	Address:
	SCP
    Vitalife Partners II	32B
    Habarzel Street

    Tel
    Aviv 69710

    Israel

	SCP
    Vitalife Partners (Israel) II
	(Collectively:
    “Vitalife”)

 

	Name
    of Preferred C Holder	Address:
	Technion
    Research and Development Foundation Ltd.

    Technion
    Investment Opportunities Fund L.P.
	Technion
    City

    Haifa
    32000

    Israel

 

	Name
    of Preferred C Holder	Address:
	Allegro
    S.àr.l

     
	11,
    Rue Beaumont

    Luxembourg,
    L-1219

    Luxembourg

 

     

     

    

 

Schedule
4

 

List
of Series D Preferred HoldersExhibit
10.1

 

Regentis Biomaterials
LTD.

 

 

 

 

 

 

 

2009
SHARE INCENTIVE PLAN

 

 

 

 

 

 

 

 

 

 

Adopted:
January 12, 2009

 

 

 

 

 

     

     

    

 

 

	 
	Regentis Biomaterials LTD.
	2009 sHARE INCENTIVE PLAN
	  

 

Unless otherwise defined, terms used herein shall
have the meaning ascribed to them in Section 2 hereof.

 

		1.	PURPOSE; TYPES OF AWARDS; CONSTRUCTION.

 

		1.1.	Purpose. The purpose of this 2009 Share Incentive Plan (as amended, the “Plan”)
is to afford an incentive to employees, directors, officers, consultants, advisors, suppliers and any other person or entity whose services
are considered valuable (collectively, the “Service Providers”) to Regentis Biomaterials Ltd., an Israeli company (the
“Company”), or any Affiliate of the Company, which now exists or hereafter is organized or acquired by the Company,
to continue as Service Providers, to increase their efforts on behalf of the Company or Affiliate and to promote the success of the Company's
business, by providing such Service Providers with opportunities to acquire a proprietary interest in the Company by the issuance of Ordinary
Shares of the Company, and the grant of options to purchase Shares, restricted Shares awards (“Restricted Shares”)
and other Share-based Awards pursuant to the Plan.

 

		1.2.	Types of Awards. The Plan is intended to enable the Company to issue Awards under varying tax regimes,
including, without limitation:

 

		(i)	pursuant and subject to the provisions of Section 102 of the Ordinance, including without limitation the
Income Tax Rules (Tax Benefits in Stock Issuance to Employees) 5763-2003 (the “Rules”) or such other rules published
by the Israeli Income Tax Authorities (the “ITA”) (such Awards, “102 Awards”). 102 Awards may either
be granted to a Trustee or without a trustee;

 

		(ii)	pursuant to Section 3(9) of the Ordinance (such Awards, “3(9) Awards”);

 

		(iii)	Incentive Stock Options within the meaning of Section 422 of the Code, or the corresponding provision
of any subsequently enacted United States federal tax statute, as amended from time to time, to be granted to Service Providers who are
deemed to be residents of the U.S. for purposes of taxation;

 

		(iv)	Nonqualified Stock Options to be granted to Service Providers who are deemed to be residents of the U.S.
for purposes of taxation; and

 

		(v)	other stock-based Awards pursuant to Section 12 hereof.

 

In addition to the issuance of Awards
under the relevant tax regimes in the United States of America and the State of Israel, the Plan contemplates issuances to Grantees in
other jurisdictions with respect to which the Committee is empowered to make the requisite adjustments in the Plan and set forth the relevant
conditions in the Company’s agreement with the Grantee in order to comply with the requirements of the tax regimes in any such jurisdictions.

 

The Plan contemplates the issuance of
Awards by the Company, both as a private company and as a publicly traded company.

 

		1.3.	Construction. To the extent any provision herein conflicts with the conditions of any relevant
tax law or regulation which are relied upon for tax relief in respect of a particular Award to a Grantee, the provisions of such law or
regulation shall prevail over those of the Plan and the Committee is empowered hereunder to interpret and enforce the said prevailing
provisions.

 

    - 2 - 

     

    

 

		2.	DEFINITIONS.

 

		2.1.	Terms Generally. The definitions of terms herein shall apply equally to the singular and plural
forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter
forms. The words “include”, “includes” and “including” shall be deemed to be followed by the phrase
“without limitation”. Unless the context requires otherwise (i) any definition of or reference to any agreement, instrument
or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended,
restated, supplemented or otherwise modified (subject to any restrictions on such amendments, restatements, supplements or modifications
set forth therein or herein), (ii) references to any law, constitution, statute, treaty, regulation, rule or ordinance, including
any section or other part thereof shall refer to that it as amended from time to time and shall include any successor law, (iii) reference
to a person shall means an individual, partnership, corporation, limited liability company, association, trust, unincorporated organization,
or a government or agency or political subdivision thereof, (iv) the words “herein”, “hereof” and “hereunder”,
and words of similar import, shall be construed to refer to this Plan in its entirety and not to any particular provision hereof and (v) all
references herein to Sections shall be construed to refer to Sections to this Plan.

 

		2.2.	Defined Terms. The following terms shall have the meanings ascribed to them in this Section 2:

 

		2.2.1.	“Affiliate” shall mean an affiliate of, or person affiliated with, a specified person
or company or other trade or business that directly, or indirectly through one or more intermediaries, controls, is controlled by or is
under common control with such person within the meaning of Rule 405 of Regulation C under the Securities Act, including, without limitation,
any Subsidiary. For the purpose of Options granted pursuant to Section 102 shall mean also an “employing company” within the
meaning of Section 102(a) of the Ordinance.

 

		2.2.2.	“Applicable Law” shall mean any applicable law, rule, regulation, statute, pronouncement,
policy, interpretation, judgment, order or decree of any federal, provincial, state or local governmental, regulatory or adjudicative
authority or agency, of any jurisdiction, and the rules and regulations of any stock exchange or trading system on which the Shares are
then traded or listed.

 

		2.2.3.	“Award” shall mean any Restricted Share, Option or any other Share-based award, granted
to a Grantee under the Plan and any share issued pursuant to the exercise thereof.

 

		2.2.4.	“Board” shall mean the Board of Directors of the Company.

 

		2.2.5.	“Code” shall mean the United States Internal Revenue Code of 1986, as amended.

 

		2.2.6.	“Committee” shall mean a committee established by the Board to administer the Plan,
subject to Section 3.1.

 

    - 3 - 

     

    

 

		2.2.7.	“Companies Law” shall mean the Israel Companies Law-1999 and the regulations promulgated
thereunder, all as amended from time to time.

 

		2.2.8.	“Controlling Shareholder” shall have the meaning set forth in Section 32(9) of the
Ordinance.

 

		2.2.9.	“Disability” shall mean (i) the inability of a Grantee to engage in any substantial
gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which
has lasted or can be expected to last for a continuous period of not less than 12 months, as determined by a medical doctor satisfactory
to the Committee or, if applicable, (ii) as “permanent and total disability” as defined in Section 22(e)(3) of the Code, as
amended from time to time.

 

		2.2.10.	“Employee” shall mean a person who is employed by the Company or any of its Affiliates,
including, for the purpose of Section 102, an individual who is serving as an “office holder” as defined under the Companies
Law, but excluding any Controlling Shareholder.

 

		2.2.11.	“Exercise Period” shall mean the period, commencing on the date of grant of an Option,
during which an Option shall be exercisable, subject to any vesting provisions thereof and the termination provisions hereof.

 

		2.2.12.	“Exercise Price” shall mean the exercise price for each Share covered by an Option.

 

		2.2.13.	“Fair Market Value” per share as of a particular date shall mean (i) the closing sales
price per Share on the securities exchange on which the Shares are principally traded for the last preceding date on which there was a
sale of such Shares on such exchange; or (ii) if the Shares are listed on Nasdaq, the last reported price per Share on Nasdaq on the last
preceding date on which there was a sale of such Share on Nasdaq; or (iii) if the Shares are then traded in an over-the-counter market,
the average of the closing bid and asked prices for the Shares in such over-the-counter market for the last preceding date on which there
was a sale of such Shares in such market; (iv) if the Shares are not then listed on a securities exchange or market or traded in an over-the-counter
market, such value as the Committee, in its sole discretion, shall determine with full authority to determine the method for making such
determination (which may be Black-Scholes model or any other method), and which determination shall be conclusive and binding on all parties,
and shall be made after such consultations with outside legal, accounting and other experts as the Committee may deem advisable. The Committee
may maintain a written record of its method of determining such value. If the Shares are listed or quoted on more than one established
stock exchange or national market system, the Committee shall determine the appropriate exchange or system for the purpose of determination
of Fair Market Value.

 

		2.2.14.	“Grantee” shall mean a person who receives a grant of Award under the Plan, and who
at the time of grant is a Service Provider of the Company or any Affiliate thereof.

 

		2.2.15.	“Non-Employee” shall mean a consultant, adviser, service provider, Controlling Shareholder
or any other person who is not an Employee.

 

    - 4 - 

     

    

 

		2.2.16.	“Nonqualified Stock Option” shall mean any Option granted to Service Provider who is
deemed to be residents of the U.S. for purposes of taxation, which Option is not designated as, or does not meet the conditions for, an
Incentive Stock Option.

 

		2.2.17.	“Options” shall mean all options to purchase Shares granted as 102 Awards, 3(9) Awards,
Incentive Stock Options and Non-Qualified Stock Options, as well as options to purchase Shares issued under other tax regimes.

 

		2.2.18.	“Ordinance” shall mean the Israeli Income Tax Ordinance (New Version) 1961, and the
regulations promulgated thereunder, all as amended from time to time.

 

		2.2.19.	“Parent” shall mean any company (other than the Company), which now exists or is hereafter
organized, (i) in an unbroken chain of companies ending with the Company if, at the time of granting an Award, each of the companies (other
than the Company) owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one
of the other companies in such chain, or, if applicable, (ii) as defined in Section 424(e) of the Code.

 

		2.2.20.	“Retirement” shall mean a Grantee's retirement pursuant to applicable law or in accordance
with the terms of any tax-qualified retirement plan maintained by the Company or any of its affiliates in which the Grantee participates.

 

		2.2.21.	“Securities Act” shall mean Securities Act of 1933, as amended.

 

		2.2.22.	“Shares” shall mean Ordinary Shares, par value NIS 0.01 of the Company, or shares of
such other class of shares of the Company as shall be designated by the Board in respect of the relevant Award.

 

		2.2.23.	“Subsidiary” shall mean any company (other than the Company), which now exists or is
hereafter organized or acquired by the Company, (i) in an unbroken chain of companies beginning with the Company if, at the time of granting
an Award, each of the companies other than the last company in the unbroken chain owns stock possessing fifty percent (50%) or more of
the total combined voting power of all classes of stock in one of the other companies in such chain, or, if applicable, (ii) as defined
in Section 424(f) of the Code.

 

		2.2.24.	“Ten Percent Shareholder” shall mean a Grantee who, at the time an Incentive Stock
Option is granted, owns shares possessing more than ten percent (10%) of the total combined voting power of all classes of shares of the
Company or any Parent or Subsidiary.

 

		2.2.25.	“Trustee” shall mean the trustee appointed by the Committee or the Board, as the case
may be, to hold the respective Options and/or Shares (and, in relation with 102 Awards, approved by the Israeli tax authorities), if so
appointed.

 

    - 5 - 

     

    

 

		2.3.	Other Defined Terms. The following terms shall have the meanings ascribed to them in the Sections
set forth below:

 

	 	
    Term
	Section
	 	102 Awards	1.2(i)
	 	102 Capital Gains Track Options	9.1
	 	102 Non-Trustee Options	9.2
	 	102 Ordinary Income Track Options	9.1
	 	102 Trustee Options	9.1
	 	3(9) Awards	1.2(ii)
	 	Cause	6.6.3
	 	Company	1.1
	 	Effective Date	25.1
	 	Election	9.2
	 	Eligible 102 Grantees	4.2
	 	ISO Shares	8.3
	 	ITA	1.2(i)
	 	Market Stand-Off	17
	 	Merger/Sale	14.2
	 	Option Agreement	6
	 	Plan	1.1
	 	Required Holding Period	9.4
	 	Restricted Period	11.4
	 	Restricted Share Agreement	11
	 	Restricted Share Unit Agreement	12.1
	 	Restricted Shares	1.1
	 	RSU	12.1
	 	Rules	1.2(i)
	 	Service Provider(s)	1.1
	 	Successor Corporation	14.2.1
	 	Withholding Obligations	18.3

 

		3.	ADMINISTRATION.

 

		3.1.	To the extent permitted under Applicable Law and the Articles of Association and any other governing document
of the Company, the Plan shall be administered by the Committee. In the event that the Board does not create a committee to administer
the Plan, the Plan shall be administered by the Board in its entirety. In the event that an action necessary for the administration of
the Plan is required under law to be taken by the Board, then such action shall be so taken by the Board. In any such event, all references
herein to the Committee shall be construed as references to the Board.

 

		3.2.	The Committee shall consist of two or more directors of the Company, as determined by the Board. The Board
shall appoint the members of the Committee, may from time to time remove members from, or add members to, the Committee, and shall fill
vacancies in the Committee however caused, provided that the composition of the Committee shall at all times be in compliance with any
mandatory requirements of Applicable Law and subject to the Company’s Articles of Association. The Committee may select one of its
members as its Chairman and shall hold its meetings at such times and places as it shall determine. The Committee may appoint a Secretary,
who shall keep records of its meetings and shall make such rules and regulations for the conduct of its business, as it shall deem advisable
and subject to requirements of Applicable Law.

 

    - 6 - 

     

    

 

		3.3.	Subject to the terms and conditions of this Plan and any mandatory provisions of Applicable Law, and in
addition to the Committee's powers contained elsewhere in this Plan, the Committee shall have full authority in its discretion, from time
to time and at any time, to determine any of the following, or to recommend to the Board any of the following if it is not authorized
to take such action according to Applicable Law:

 

		(i)	eligible Grantees,

 

		(ii)	grants of Awards and setting the terms and provisions of option agreements (which need not be identical)
and any other agreements or instruments under which Awards are made, including, but not limited to, the number of Shares underlying each
Award,

 

		(iii)	the time or times at which Awards shall be granted,

 

		(iv)	the schedule and conditions on which Awards may be exercised (including without limitation acceleration),

 

		(v)	the Exercise Price (including without limitation re-pricing),

 

		(vi)	to interpret the Plan,

 

		(vii)	prescribe, amend and rescind rules and regulations relating to and for carrying out the Plan, as it may
deem appropriate,

 

		(viii)	the Fair Market Value of the Shares,

 

		(ix)	the tax track (capital gains, ordinary income track or any other track available under the Section 102
of the Ordinance) for the purpose of 102 Awards, and

 

		(x)	any other matter which is necessary or desirable for, or incidental to, the administration of the Plan
and any Award thereunder.

 

		3.4.	Grants of Awards shall be made pursuant to written notice to Grantees setting forth the terms of the Award.
Such notice shall designate the type of Award as one of the following: (i) a 102 Award granted to a Trustee (either as a 102 Award (capital
gain track) with Trustee or a 102 Award (ordinary income track) with Trustee), (ii) a 102 Award without a 102 Trustee, (iii) a 3(9) Award,
(iv) Incentive Stock Option, (v) Nonqualified Stock Option, or (vi) any other type of Award.

 

		3.5.	Subject to the mandatory provisions of Applicable Law, the grant of any Award, whether by the Committee
or the Board, shall be deemed to include an authorization of the issuance of Shares upon the due exercise thereof.

 

		3.6.	The authority granted hereunder includes the authority to modify Awards to eligible individuals who are
foreign nationals or are individuals who are employed outside Israel to recognize differences in local law, tax policy or custom, in order
to effectuate the purposes of the Plan but without amending the Plan. The Committee shall have the authority to grant, in its discretion,
to the holder of an outstanding Award, in exchange for the surrender and cancellation of such Award, a new Award having an exercise price
lower than provided in the Award so surrendered and canceled and containing such other terms and conditions as the Committee may prescribe
in accordance with the provisions of the Plan or to set a new exercise price for the same Award lower than that previously provided in
the Award.

 

    - 7 - 

     

    

 

		3.7.	All decisions, determination and interpretations of the Committee shall be final and binding on all Grantees
of any Awards under this Plan, unless otherwise determined by the Board. No member of the Committee shall be liable for any action taken
or determination made in good faith with respect to the Plan or any Award granted hereunder.

 

		4.	ELIGIBILITY.

 

		4.1.	Awards may be granted to Service Providers of the Company and any Affiliate thereof, taking into account
the qualification under each tax regime pursuant to which such Awards are granted. A person who has been granted an Award hereunder may
be granted additional Awards, if the Committee shall so determine, subject to the limitations herein. In determining the persons to whom
Awards shall be granted and the number of Shares to be covered by each Award, the Committee shall take into account the duties of the
respective persons, their present and potential contributions to the success of the Company and such other factors as the Committee shall
deem relevant in connection with accomplishing the purpose of the Plan.

 

		4.2.	Subject to Applicable Law, 102 Awards may not be granted to Controlling Shareholders and may only be granted
to Employees, including officers and directors, of the Company or any Affiliate thereof, who are Israeli residents (“Eligible
102 Grantees”). Awards to Eligible 102 Grantees in Israel shall be 102 Awards. Eligible 102 Grantees may receive only 102 Awards,
which may either be grants to a Trustee or grants under Section 102 without a trustee. Unless otherwise permitted by the Ordinance and
the Rules, no 102 Awards to a Trustee may be granted until the expiration of thirty (30) days after the requisite filings under the Ordinance
and the Rules have been appropriately made with the ITA.

 

		4.3.	Subject to Applicable Law, Non-Employees who are Israeli residents and are not Eligible 102 Grantees may
only be granted 3(9) Awards under this Plan.

 

		5.	SHARES.

 

The initial number of Shares reserved
for the grant of Awards under the Plan shall be 88,959 Shares. The class of said Shares shall be designated by the Board with respect
to each Award and the notice of grant shall reflect such designation. Any share underlying an Award granted hereunder which has expired,
or was cancelled or terminated or forfeited for any reason without having been exercised, shall be automatically, and without any further
action on the part of the Company or any Grantee, returned to the “pool” of reserved Shares hereunder and shall again be available
for grant for the purposes of this Plan (unless this Plan shall have been terminated) or unless the Board determines otherwise. The Board
may, subject to any other approvals required under any Applicable Law, increase or decrease the number of Shares to be reserved under
the Plan. Such Shares may, in whole or in part, be authorized but unissued Shares, or Shares that shall have been or may be reacquired
by the Company (to the extent permitted pursuant to the Companies Law) or by a trustee appointed by the Board under the relevant provisions
of the Ordinance, the Companies Law or any equivalent provision. Any Shares which are not subject to outstanding options at the termination
of the Plan shall cease to be reserved for the purpose of the Plan, but until termination of the Plan, the Company shall at all times
reserve a sufficient number of Shares to meet the requirements of the Plan.

 

    - 8 - 

     

    

 

		6.	TERMS AND CONDITIONS OF OPTIONS.

 

Each Option granted pursuant to the
Plan shall be evidenced by a written agreement between the Company and the Grantee or a written notice delivered by the Company and accepted
by the Grantee (the “Option Agreement”), in such form and containing such terms and conditions as the Committee shall
from time to time approve, which Option Agreement shall comply with and be subject to the following terms and conditions, unless otherwise
specifically provided in such Option Agreement or the terms referred to in Sections 9 and 10 below. For purposes of interpreting this
Section 6, a director's service as a member of the Board or the services of an officer, as the case may be, shall be deemed to be employment
with the Company or its Subsidiary or Affiliate.

 

		6.1.	Number of Shares. Each Option Agreement shall state the number of Shares covered by the Option.

 

		6.2.	Type of Option. Each Option Agreement shall specifically state the type of Option granted thereunder
and whether it constitutes an Incentive Stock Option, Nonqualified Stock Option, 102 Option Award and the relevant track, 3(9) Option
Award, or otherwise.

 

		6.3.	Exercise Price. Each Option Agreement shall state the Exercise Price, which, in the case of an
Incentive Stock Option, shall not be less than one hundred percent (100%) of the Fair Market Value of the Shares covered by the Option
on the date of grant or such other amount as may be required pursuant to the Code. In the case of any other Option, the per share Exercise
Price shall be equal to the amount determined by the Committee. In the case of an Incentive Stock Option granted to any Ten-Percent Shareholder,
the Exercise Price shall be no less than 110% of the Fair Market Value of the Shares covered by the Option on the date of grant. In no
event shall the Exercise Price of an Option be less than the par value of the shares for which such Option is exercisable. Subject to
Section 3 and to the foregoing, the Committee may reduce the Exercise Price of any outstanding Option. The Exercise Price shall also be
subject to adjustment as provided in Section 14 hereof.

 

		6.4.	Manner of Exercise. An Option may be exercised, as to any or all Shares as to which the Option
has become exercisable, by written notice delivered in person or by mail to the Secretary of the Company or to such other person as determined
by the Committee, specifying the number of Shares with respect to which the Option is being exercised, accompanied by payment of the Exercise
Price for such Shares in the manner specified in the following sentence. The Exercise Price shall be paid in full with respect to each
Share, at the time of exercise, either in (i) cash (either in US Dollars or in New Israeli Shekels, in accordance with the exchange rate
at date of exercise), (ii) if the Company’s shares are publicly traded, all or part of the Exercise Price and any withholding taxes
may be paid by the delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker approved by the Company
to sell Shares and to deliver all or part of the sales proceeds to the Company or the Trustee, (iii) if the Company’s shares are
publicly traded, all or part of the Exercise Price and any withholding taxes may be paid by the delivery (on a form prescribed by the
Company) of an irrevocable direction to pledge Shares to a securities broker or lender approved by the Company, as security for a loan,
and to deliver all or part of the loan proceeds to the Company or the Trustee, or (iv) in such other manner as the Committee shall determine,
which may include procedures for cashless exercise.

 

    - 9 - 

     

    

 

		6.5.	Term and Vesting of Options. Each Option Agreement shall provide the vesting schedule for the Option
as determined by the Committee. To the extent permitted under Applicable Law, the Committee shall have the authority to determine the
vesting schedule and accelerate the vesting of any outstanding Option at such time and under such circumstances as it, in its sole discretion,
deems appropriate. Unless otherwise resolved by the Committee and stated in the Option Agreement, and subject to Sections 6.6 and 6.7
hereof, Options shall vest and become exercisable under the following schedule: twenty-five percent (25%) of the Shares covered by the
Option, on the first anniversary of the date on which such Option is granted, provided that the Grantee remains continuously employed
by or in the service of the Company or its Subsidiary or Affiliate for that one year, and six and one-quarter percent (6.25%) of the Shares
covered by the Option at the end of each subsequent quarter, provided that the Grantee remains continuously employed by or in the service
of the Company or its Subsidiary or Affiliate for that quarter, over the course of the following three (3) years of continued employment
by or service for the Company or its Subsidiary or Affiliate. The Option Agreement may contain performance goals and measurements, and
the provisions with respect to any Option need not be the same as the provisions with respect to any other Option. The Exercise Period
of an Option will be ten (10) years from the date of grant of the Option unless otherwise determined by the Committee, but subject to
the vesting provisions described above and the early termination provisions set forth in Sections 6.6 and 6.7 hereof; provided, however,
that in the case of an Incentive Stock Option granted to a Ten Percent Shareholder, such Exercise Period shall not exceed five (5) years
from the date of grant of such Option. At the expiration of the Exercise Period, all unexercised Options shall become null and void.

 

		6.6.	Termination.

 

		6.6.1.	Except as provided in this Section 6.6 and in Section 6.7 hereof, an Option may not be exercised unless
the Grantee is then in the employ of or maintaining a director, officer, consultant, advisor or supplier relationship with the Company
or a Subsidiary or Affiliate thereof or, in the case of an Incentive Stock Option, a company or a parent or subsidiary company of such
company issuing or assuming the Option in a transaction to which Section 424(a) of the Code applies, and unless the Grantee has remained
continuously so employed or in the director, officer, supplier, consultant, or advisor relationship since the date of grant of the Option.
In the event that the employment or director, officer or consultant, advisor or supplier relationship of a Grantee shall terminate (other
than by reason of death, Disability or Retirement), all Options of such Grantee that are vested and exercisable at the time of such termination
may, unless earlier terminated in accordance with their terms, be exercised within up to ninety (90) days after the date of such termination
(or such different period as the Committee shall prescribe); provided, however, that if the Company (or the Subsidiary or Affiliate, when
applicable) shall terminate the Grantee’s employment or service for Cause (as defined below) or if following the Grantee’s
termination of employment, circumstances arise or are discovered with respect to the Grantee that would have constituted Cause for termination
of his or her employment or service, all Options theretofore granted to such Grantee (whether vested or not) shall, to the extent not
theretofore exercised, terminate on the date of such termination (or on which such circumstance arise or are discovered, as the case may
be) unless otherwise determined by the Committee.

 

    - 10 - 

     

    

 

		6.6.2.	In the case of a Grantee whose principal employer is a Subsidiary or Affiliate, the Grantee’s employment
shall also be deemed terminated for purposes of this Section 6.6 as of the date on which such principal employer ceases to be a Subsidiary
or Affiliate. Notwithstanding anything to the contrary, the Committee, in its absolute discretion may, on such terms and conditions as
it may determine appropriate, extend the periods for which the Options held by any individual may continue to vest and be exercisable;
provided, that such Options may lose their status as Incentive Stock Options under applicable law and be deemed Nonqualified Stock Options
in the event that the period of vesting and/or exercisability of any option is extended beyond the later of: (i) one hundred and eighty
(180) days after the date of cessation of employment or performance of services; or (ii) the applicable period under Section 6.7 below.

 

		6.6.3.	For purposes of this Plan, the term “Cause” shall mean any of the following: (a) fraud,
embezzlement or felony or similar act by the Grantee; (b) an act of moral turpitude by the Grantee, or any similar act, to the extent
that such act causes significant injury to the reputation, business or business relationship of the Company (or a Subsidiary or Affiliate,
when applicable); (c) any material breach by the Grantee of an agreement between the Company or any Subsidiary or Affiliate and the Grantee
(including material breach of confidentiality, non-competition or non-solicitation covenants); or (d) any circumstances that constitute
grounds for termination for cause under the Grantee’s employment, consulting or service agreement with the Company or Subsidiary
or Affiliate, to the extent applicable.

 

		6.7.	Death, Disability or Retirement of Grantee. If a Grantee shall die while employed by, or performing
service for, the Company or a Subsidiary, or within the three (3) month period after the date of termination of such Grantee's employment
or service (or within such different period as the Committee may have provided pursuant to Section 6.6 hereof), or if the Grantee's employment
or service shall terminate by reason of Disability, all Options theretofore granted to such Grantee may (to the extent otherwise vested
and exercisable and unless earlier terminated in accordance with their terms), be exercised by the Grantee or by the Grantee's estate
or by a person who acquired the right to exercise such Options by bequest or inheritance or otherwise by result of death or Disability
of the Grantee, at any time within one (1) year after the death or Disability of the Grantee (or such different period as the Committee
shall prescribe). In the event that an Option granted hereunder shall be exercised by the legal representatives of a deceased or former
Grantee, written notice of such exercise shall be accompanied by a certified copy of letters testamentary or equivalent proof of the right
of such legal representative to exercise such Option. In the event that the employment or service of a Grantee shall terminate on account
of such Grantee's Retirement, all Options of such Grantee that are exercisable at the time of such Retirement may, unless earlier terminated
in accordance with their terms, be exercised at any time within the three (3) month period after the date of such Retirement (or such
different period as the Committee shall prescribe).

 

		6.8.	Suspension of Vesting. Unless the Board of Directors or the Committee provides otherwise, vesting
of Options granted hereunder shall be suspended during any unpaid leave of absence, other than in the case of any (a) leave of absence
which was pre-approved by the Company, or (b) transfers between locations of the Company or between the Company, any Affiliate, or any
respective successor thereof.

 

    - 11 - 

     

    

 

		6.9.	Voting Proxy. Until immediately after the listing for trading on a stock exchange or market or
trading system of the Company’s (or the Successor Corporation’s) shares, the right to vote any Shares acquired under this
Plan pursuant to an Award shall, unless otherwise determined by the Committee, be given by the Grantee or the Trustee (if so requested
from the Trustee and agreed by the Trustee), as the case may be, pursuant to an irrevocable proxy, to the person or persons designated
by the Board. All Awards granted hereunder shall be conditioned upon the execution of such irrevocable proxy. So long as any such Shares
are held by a Trustee (and unless a proxy was given by the Trustee as aforesaid), such Shares shall be voted by the Trustee, such Shares
shall be voted in the same proportion as the result of the shareholder vote at the shareholders meeting or written consent in respect
of which the Shares held by the Trustee are being voted. Any irrevocable proxy granted pursuant hereto shall be of no force or effect
immediately after the immediately after the listing for trading on a stock exchange or market or trading system of the Company’s
(or the Successor Corporation’s) shares.

 

		6.10.	Other Provisions. The Option Agreement evidencing Awards under the Plan shall contain such other
terms and conditions not inconsistent with the Plan as the Committee may determine, at or after the date of grant, including without limitation,
provisions in connection with the restrictions on transferring the Awards, which shall be binding upon the Grantees and other terms and
conditions as the Committee shall deem appropriate.

 

		7.	NONQUALIFIED STOCK OPTIONS.

 

Options granted pursuant to this Section
7 are intended to constitute Nonqualified Stock Options and shall be subject to the general terms and conditions specified in Section
6 hereof and other provisions of the Plan, except for any provisions of the Plan applying to Options under different tax laws or regulations.

 

		8.	INCENTIVE STOCK OPTIONS.

 

Options granted pursuant to this Section
8 are intended to constitute Incentive Stock Options and shall be granted subject to the following special terms and conditions, the general
terms and conditions specified in Section 6 hereof and other provisions of the Plan, except for any provisions of the Plan applying to
Options under different tax laws or regulations:

 

		8.1.	Value of Shares. The aggregate Fair Market Value (determined as of the date the Incentive Stock
Option is granted) of the Shares with respect to which all Incentive Stock Options granted under this Plan and all other option plans
of any Subsidiary or Affiliate become exercisable for the first time by each Grantee during any calendar year shall not exceed one hundred
thousand United States dollars ($100,000) with respect to such Grantee. To the extent that the aggregate Fair Market Value of Shares with
respect to which the Incentive Stock Options are exercisable for the first time by any Grantee during any calendar years exceeds one hundred
thousand United States dollars ($100,000), such Options shall be treated as Nonqualified Stock Options. The foregoing shall be applied
by taking options into account in the order in which they were granted, with the Fair Market Value of any Share to be determined at the
time of the grant of the Option. In the event the foregoing results in the portion of an Incentive Stock Option exceeding the one hundred
thousand United States dollars ($100,000) limitation, only such excess shall be treated as a Nonqualified Stock Option.

 

		8.2.	Ten Percent Shareholder. In the case of an Incentive Stock Option granted to a Ten Percent Shareholder,
(i) the Exercise Price shall not be less than one hundred and ten percent (110%) of the Fair Market Value of the Shares on the date of
grant of such Incentive Stock Option, and (ii) the Exercise Period shall not exceed five (5) years from the date of grant of such Incentive
Stock Option.

 

    - 12 - 

     

    

 

		8.3.	Incentive Stock Option Lock-Up Period. No disposition of Shares received pursuant to the exercise
of Incentive Stock Options (“ISO Shares”), shall be made by the Grantee within 2 years from the date of grant, nor
within 1 year after the transfer of such ISO Shares to him. To the extent that the Grantee violates the aforementioned limitations, the
Incentive Stock Options shall be deemed to be Nonqualified Stock Options.

 

		8.4.	Approval. The status of any ISO Shares shall be subject to approval of the Plan by the Company’s
shareholders, such approval to be provided 12 months before or after the date of adoption of the Plan by the Board of Directors.

 

		8.5.	Exercise Following Termination. Notwithstanding anything else in this Plan to the contrary, Incentive
Stock Options that are not exercised within ninety (90) days following termination of Grantee’s employment in the Company or its
Affiliates and Subsidiaries, or within one year in case of termination of Grantee’s employment in the Company or its Affiliates
and Subsidiaries due to a disability (within the meaning of section 22(e)(3) of the Code), shall be deemed to be Nonqualified Stock Options.

 

		8.6.	Adjustments to Incentive Stock Options. Any Option Agreement providing for the grant of Incentive
Stock Options shall indicate that adjustments made pursuant to the Plan with respect to Incentive Stock Options could constitute a “modification”
of such Incentive Stock Options (as that term is defined in Section 424(h) of the Code) or could cause adverse tax consequences for the
holder of such Incentive Stock Options and that the holder should consult with his or her tax advisor regarding the consequences of such
“modification” on his or her income tax treatment with respect to the Incentive Stock Option.

 

		8.7.	Notice to Company of Disqualifying Disposition. Each Grantee who receives an Incentive Stock Option
must agree to notify the Company in writing immediately after the Grantee makes a Disqualifying Disposition of any ISO Shares. A “Disqualifying
Disposition” is any disposition (including any sale) of such ISO Shares before the later of (i) two years after the date the
Grantee was granted the Incentive Stock Option, or (ii) one year after the date the Grantee acquired Shares by exercising the Incentive
Stock Option. If the Grantee dies before such ISO Shares are sold, these holding period requirements do not apply and no disposition of
the ISO Shares will be deemed a Disqualifying Disposition.

 

		9.	102 OPTION AWARDS.

 

		9.1.	Options granted pursuant to this Section 9 are intended to be granted pursuant to Section 102 of the Ordinance
pursuant to either (a) Section 102(b)(2) thereof as capital gains track options (“102 Capital Gains Track Options”),
or (b) Section 102(b)(1) thereof as ordinary income track options (“102 Ordinary Income Track Options”; together with
102 Capital Gains Track Options, “102 Trustee Options”). 102 Trustee Options shall be granted subject to the following
special terms and conditions contained in this Section 9, the general terms and conditions specified in Section 6 hereof and other provisions
of the Plan, except for any provisions of the Plan applying to Options under different tax laws or regulations.

 

		9.2.	The Company may grant only one type of 102 Trustee Option at any given time to all Grantees who are to
be granted 102 Trustee Options pursuant to this Plan, and shall file an election with the ITA regarding the type of 102 Trustee Option
it elects to grant before the date of grant of any 102 Trustee Options (the “Election”). Such Election shall also apply
to any bonus shares received by any Grantee as a result of holding the 102 Trustee Options. The Company may change the type of 102 Trustee
Option that it elects to grant only after the passage of at least 12 months from the end of the year in which the first grant was made
in accordance with the previous Election, or as otherwise provided by Applicable Law. Any Election shall not prevent the Company from
granting Options, pursuant to Section 102(c) of the Ordinance without a Trustee (“102 Non-Trustee Options”).

 

    - 13 - 

     

    

 

		9.3.	Each 102 Trustee Option will be deemed granted on the date stated in a written notice to be provided by
the Company, provided that on or before such date (i) the Company has provided such notice to the Trustee and (ii) the Grantee has signed
all documents required pursuant to Applicable Law and under the Plan.

 

		9.4.	Each 102 Trustee Option, each Share issued pursuant to the exercise of any 102 Trustee Option, and any
rights granted thereunder, including, without limitation, bonus shares, shall be allotted and issued to and registered in the name of
the Trustee and shall be held in trust for the benefit of the Grantee for a period of not less than the requisite period prescribed by
the Ordinance and the Rules or such longer period as set by the Committee (the “Required Holding Period”). In the event
that the requirements under Section 102 to qualify an Option as a 102 Trustee Option are not met, then the Option may be treated as a
102 Non-Trustee Option, all in accordance with the provisions of Section 102 and the Rules. After termination of the Required Holding
Period, the Trustee may release such 102 Trustee Option and any such Shares, provided that (i) the Trustee has received an acknowledgment
from the ITA that the Grantee has paid any applicable taxes due pursuant to the Ordinance or (ii) the Trustee and/or the Company and/or
its Affiliate withholds any applicable taxes due pursuant to the Ordinance arising from the 102 Trustee Options and/or any Shares allotted
or issued upon exercise of such 102 Trustee Options. The Trustee shall not release any 102 Trustee Options or Shares issued upon exercise
thereof prior to the payment in full of the Grantee’s tax liabilities arising from such 102 Trustee Options and/or Shares or the
withholding referred to in (ii) above.

 

		9.5.	Each 102 Trustee Option shall be subject to the relevant terms of the Ordinance and the Rules, which shall
be deemed an integral part of the 102 Trustee Option and shall prevail over any term contained in the Plan or Option Agreement which is
not consistent therewith. Any provision of the Ordinance, the Rules and any approvals by the Income Tax Commissioner not expressly specified
in this Plan or Option Agreement which, as determined by the Committee, are necessary to receive or maintain any tax benefit pursuant
to Section 102 shall be binding on the Grantee. The Grantee granted a 102 Trustee Option shall comply with the Ordinance and the terms
and conditions of the Trust Agreement entered into between the Company and the Trustee. The Grantee agrees to execute any and all documents,
which the Company and/or its Affiliates and/or the Trustee may reasonably determine to be necessary in order to comply with the Ordinance
and the Rules.

 

		9.6.	During the Required Holding Period, the Grantee shall not release from trust or sell, assign, transfer
or give as collateral, the Shares issuable upon the exercise of a 102 Trustee Option and/or any securities issued or distributed with
respect thereto, until the expiration of the Required Holding Period. Notwithstanding the above, if any such sale or release occurs during
the Required Holding Period it will result in adverse tax consequences to the Grantee under Section 102 of the Ordinance and the Rules,
which shall apply to and shall be borne solely by such Grantee. Subject to the foregoing, the Trustee may, pursuant to a written request
from the Grantee, release and transfer such Shares to a designated third party, provided that both of the following conditions have been
fulfilled prior to such release or transfer: (i) payment has been made to the ITA of all taxes required to be paid upon the release and
transfer of the Shares, and confirmation of such payment has been received by the Trustee and (ii) the Trustee has received written confirmation
from the Company that all requirements for such release and transfer have been fulfilled according to the terms of the Company’s
corporate documents, the Plan, the Option Agreement and any Applicable Law.

 

    - 14 - 

     

    

 

		9.7.	If a 102 Trustee Option is exercised during the Required Holding Period, the Shares issued upon such exercise
shall be issued in the name of the Trustee for the benefit of the Grantee. If such 102 Trustee Option is exercised after the expiration
of the Required Holding Period, the Shares issued upon such exercise shall, at the election of the Grantee, either (i) be issued in the
name of the Trustee, or (ii) be issued to the Grantee, provided that the Grantee first complies with all applicable provisions of the
Plan and all taxes with respect thereto shall have been fully paid to the ITA.

 

		9.8.	The foregoing provisions of this Section 9 relating to 102 Trustee Options shall not apply with respect
to 102 Non-Trustee Options, which shall, however, be subject to the relevant provisions of Section 102 and the Rules.

 

		9.9.	Upon receipt of a 102 Trustee Option, the Grantee will sign an undertaking to release the Trustee from
any liability with respect to any action or decision duly taken and executed in good faith by the Trustee in relation to the Plan, or
any 102 Trustee Option or Share granted to such Grantee thereunder.

 

		10.	3(9) OPTION AWARD.

 

		10.1.	Options granted pursuant to this Section 10 are intended to constitute a 3(9) Option Award and shall be
granted subject to the general terms and conditions specified in Section 6 hereof and other provisions of the Plan, except for any provisions
of the Plan applying to Options under different tax laws or regulations.

 

		10.2.	To the extent required by the Ordinance or the ITA or otherwise deemed by the Committee prudent or advisable,
the 3(9) Option Awards granted pursuant to the Plan shall be issued to a Trustee nominated by the Committee in accordance with the provisions
of the Ordinance. In such event, the Trustee shall hold such Options in trust, until exercised by the Grantee, pursuant to the Company's
instructions from time to time as set forth in a trust agreement, which will be entered into between the Company and the Trustee. If determined
by the Board of Directors or the Committee, and subject to such trust agreement the Trustee shall be responsible for withholding any taxes
to which a Grantee may become liable upon the exercise of Options.

 

		11.	RESTRICTED SHARES.

 

The Committee may award Restricted
Shares to any eligible Grantee, including under Section 102 of the Ordinance. Each Award of Restricted Shares under the Plan shall be
evidenced by a written agreement between the Company and the Grantee (the “Restricted Share Agreement”), in such form
as the Committee shall from time to time approve. The Restricted Share Agreement shall comply with and be subject to the following terms
and conditions, unless otherwise specifically provided in such Agreement:

 

		11.1.	Number of Shares. Each Restricted Share Agreement shall state the number of Shares covered by an
Award.

 

		11.2.	Purchase Price. Each Restricted Share Agreement may state an amount of purchase price to be paid
by the Grantee in consideration for the issuance of the Restricted Shares and the terms of payment thereof, which may include, payment
by issuance of promissory notes or other evidence of indebtedness on such terms and conditions as determined by the Committee.

 

    - 15 - 

     

    

 

		11.3.	Vesting. Each Restricted Share Agreement shall provide the vesting schedule for the Restricted
Shares as determined by the Committee, provided that (to the extent permitted under Applicable Law) the Committee shall have the authority
to determine the vesting schedule and accelerate the vesting of any outstanding Restricted Share at such time and under such circumstances
as it, in its sole discretion, deems appropriate. Unless otherwise resolved by the Committee and stated in the Restricted Share Agreement,
Restricted Shares shall vest in the same vesting schedule as set forth in Section 6.5 hereof.

 

		11.4.	Restrictions. Restricted Shares may not be sold, assigned, transferred, pledged, hypothecated or
otherwise disposed of, except by will or the laws of descent and distribution, for such period as the Committee shall determine from the
date on which the Award is granted (the “Restricted Period”). The Committee may also impose such additional or alternative
restrictions and conditions on the Restricted Shares, as it deems appropriate, including the satisfaction of performance criteria. Such
performance criteria may include, but are not limited to, sales, earnings before interest and taxes, return on investment, earnings per
share, any combination of the foregoing or rate of growth of any of the foregoing, as determined by the Committee. Certificates for shares
issued pursuant to Restricted Share Awards shall bear an appropriate legend referring to such restrictions, and any attempt to dispose
of any such shares in contravention of such restrictions shall be null and void and without effect. Such certificates may, if so determined
by the Committee, be held in escrow by an escrow agent appointed by the Committee, or, if a Restricted Share Award is made pursuant to
Section 102, by the Trustee. In determining the Restricted Period of an Award the Committee may provide that the foregoing restrictions
shall lapse with respect to specified percentages of the awarded Restricted Shares on successive anniversaries of the date of such Award.
To the extent required by the Ordinance or the ITA, the Restricted Shares issued pursuant to Section 102 of the Ordinance shall be issued
to the Trustee in accordance with the provisions of the Ordinance and the Restricted Shares shall be held for the benefit of the Grantee
for such period as may be required by the Ordinance.

 

		11.5.	Adjustment of Performance Goals. The Committee may adjust performance goals to take into account
changes in law and accounting and tax rules and to make such adjustments as the Committee deems necessary or appropriate to reflect the
inclusion or the exclusion of the impact of extraordinary or unusual items, events or circumstances. The Committee also may adjust the
performance goals by reducing the amount to be received by any Grantee pursuant to an Award if and to the extent that the Committee deems
it appropriate.

 

		11.6.	Forfeiture. Subject to such exceptions as may be determined by the Committee, if the Grantee's
continuous employment with the Company or any Subsidiary or Affiliate shall terminate for any reason prior to the expiration of the vesting
date or Restricted Period of an Award or prior to the payment in full of the purchase price of any Restricted Shares with respect to which
the vesting date or the Restricted Period has expired, any shares remaining subject to vesting or restrictions or with respect to which
the purchase price has not been paid in full, shall thereupon be forfeited and shall be deemed transferred to, and reacquired by, or cancelled
by, as the case may be, the Company or a Subsidiary at no cost to the Company or Subsidiary, subject to all Applicable Laws. Upon forfeiture
of Restricted Shares, the Grantee shall have no further rights with respect to such Restricted Shares.

 

		11.7.	Ownership. During the Restricted Period the Grantee shall possess all incidents of ownership of
such Restricted Shares, subject to Section 6.9 and Section 11.4, including the right to receive dividends with respect to such shares.
All distributions, if any, received by a Grantee with respect to Restricted Shares as a result of any stock split, stock dividend, combination
of shares, or other similar transaction shall be subject to the restrictions applicable to the original Award.

 

    - 16 - 

     

    

 

		12.	RESTRICTED SHARE UNITS.

 

		12.1.	A Restricted Share Unit (an “RSU”) is an Award covering a number of Shares that is
settled by issuance of those Shares. An RSU may be awarded to any eligible Grantee, including under Section 102 of the Ordinance. Each
grant of RSUs under the Plan shall be evidenced by a written agreement between the Company and the Grantee (the “Restricted Share
Unit Agreement”), in such form as the Committee shall from time to time approve. Such RSUs shall be subject to all applicable
terms of the Plan and may be subject to any other terms that are not inconsistent with the Plan. The provisions of the various Restricted
Share Unit Agreements entered into under the Plan need not be identical. RSUs may be granted in consideration of a reduction in the recipient’s
other compensation.

 

		12.2.	Other than the par value of the Shares, no payment of cash shall be required as consideration for RSUs.
RSUs may or may not be subject to vesting. Vesting shall occur, in full or in installments, upon satisfaction of the conditions specified
in the Restricted Share Unit Agreement.

 

		12.3.	Without limitation of Section 6.9, no voting or dividend rights as a shareholder shall exist prior to
the actual issuance of Shares in the name of the Grantee. Notwithstanding anything else in this Plan (as may be amended from time to time)
to the contrary, unless otherwise specified by the Committee, each RSU shall be for a term of seven (7) years. Each Restricted Share Unit
Agreement shall specify its term and any conditions on the time or times for settlement, and provide for expiration prior to the end of
its term in the event of termination of employment or service providing to the Company, and may provide for earlier settlement in the
event of the Grantee’s death, Disability or other events.

 

		12.4.	Settlement of vested RSUs shall be made in the form of Shares. Distribution to a Grantee of an amount
(or amounts) from settlement of vested RSUs can be deferred to a date after settlement as determined by the Committee. The amount of a
deferred distribution may be increased by an interest factor or by dividend equivalents. Until the grant of RSUs is settled, the number
of such RSUs shall be subject to adjustment pursuant hereto.

 

		13.	OTHER SHARE OR SHARE-BASED AWARDS.

 

The Committee may grant other Awards
under the Plan pursuant to which Shares (which may, but need not, be Restricted Shares pursuant to Section 11 hereof), cash or a combination
thereof, are or may in the future be acquired or received, or Awards denominated in stock units, including units valued on the basis of
measures other than market value. The Committee may also grant stock appreciation rights without the grant of an accompanying option,
which rights shall permit the Grantees to receive, at the time of any exercise of such rights, cash equal to the amount by which the Fair
Market Value of all Shares in respect to which the right was granted exceeds the exercise price thereof. The Committee may, and it is
hereby deemed to be an Award under the terms of the Plan, grant to Grantees (including employees) the opportunity to purchase Shares of
the Company in connection with any public offerings of the Company’s securities. Such other Share based Awards may be granted alone,
in addition to, or in tandem with any Award of any type granted under the plan and must be consistent with the purposes of the Plan.

 

    - 17 - 

     

    

 

		14.	EFFECT OF CERTAIN CHANGES.

 

		14.1.	General. In the event of a subdivision of the outstanding share capital of the Company, any payment
of a stock dividend (distribution of bonus shares), a recapitalization, a reorganization (which may include a combination or exchange
of shares), a consolidation, a stock split, a reverse stock split, a spin-off or other corporate divestiture or division, a reclassification
or other similar occurrence, the Committee shall make such adjustments as determined by the Committee to be appropriate in order to adjust
(i) the number of Shares available for grants of Awards, (ii) the number of Shares covered by outstanding Awards, and (iii) the exercise
price per share covered by any Award; provided, however, that any fractional shares resulting from such adjustment shall be rounded down
to the nearest whole share and that the Company shall have no obligation to make any cash or other payment with respect to such fractional
shares.

 

		14.2.	Merger and Sale of Company. In the event of (i) a sale of all or substantially all of the assets
of the Company; or (ii) a sale (including an exchange) of all or substantially all of the shares of the Company , or an acquisition by
a shareholder of the Company or by an Affiliate of such shareholder, of all the shares of the Company held by other shareholders or by
other shareholders who are not Affiliated with such acquiring party; (iii) a merger, consolidation, amalgamation or like transaction of
the Company with or into another corporation; (iv) a scheme of arrangement for the purpose of effecting such sale, merger or amalgamation;
or (v) such other transaction that is determined by the Committee to be a transaction having a similar effect (all such transactions being
herein referred to as a “Merger/Sale”), then, without the Grantee’s consent and action:

 

		14.2.1.	Unless otherwise determined by the Committee in its sole and absolute discretion, any Award then outstanding
shall be assumed or an equivalent Award shall be substituted by such successor corporation of the Merger/Sale or any parent or Affiliate
thereof as determined by the Board in its discretion (the “Successor Corporation”), under substantially the same terms
as the Award;

 

For the purposes
of this Section 14.2.1, the Award shall be considered assumed if, following a Merger/Sale, the Award confers on the holder thereof the
right to purchase or receive, for each Share underlying an Award immediately prior to the Merger/Sale, either (i) the consideration (whether
stock, cash, or other securities or property) distributed to or received by holders of Shares in the Merger/Sale for each Share held on
the effective date of the Merger/Sale (and if holders were offered a choice of consideration, the type of consideration chosen by the
holders of a majority of the outstanding Shares), which may be subject to vesting and other terms as determined by the Committee in its
discretion, or (ii) regardless of the consideration received by the holders of Shares in the Merger/Sale, solely shares (or their equivalent)
of the Successor Corporation at a value to be determined by the Committee in its discretion, which may be subject to vesting and other
terms as determined by the Committee in its discretion. The foregoing shall not limit the Committee authority to determine, in its sole
discretion, that in lieu of such assumption or substitution of Awards for Awards of the Successor Corporation, such Award will be substituted
for any other type of asset or property, including under Section 14.2.2 hereunder.

 

    - 18 - 

     

    

 

		14.2.2.	In the event that the Awards are not assumed or substituted by an equivalent Award, then the Committee
may (but shall not be obligated to), in lieu of such assumption or substitution of the Award and in its sole discretion, (i) provide for
the Grantee to have the right to exercise the Award, or otherwise for the acceleration of vesting of such Award, as to all or part of
the Shares, including Shares covered by the Award which would not otherwise be exercisable or vested, under such terms and conditions
as the Committee shall determine, including the cancellation of all unexercised Awards upon closing of the Merger/Sale; and/or (ii) provide
for the cancellation of each outstanding Award at the closing of such Merger/Sale, and payment to the Grantee of an amount in cash as
determined by the Committee to be fair in the circumstances (with full authority to determine the method for making such determination,
which may be Black-Scholes model or any other method, and which determination shall be conclusive and binding on all parties), and subject
to such terms and conditions as determined by the Committee.

 

		14.2.3.	Notwithstanding the foregoing, in the event of a Merger/Sale, the Committee may determine, in its sole
discretion, that upon completion of such Merger/Sale, the terms of any Award be otherwise amended, modified or terminated, as the Committee
shall deem in good faith to be appropriate, and if an Option Award, that the Option Award shall confer the right to purchase or receive
any other security or asset, or any combination thereof, or that its terms be otherwise amended, modified or terminated, as the Committee
shall deem in good faith to be appropriate. Neither the authorities and powers of the Committee under this Section 14.2.2, nor the exercise
or implementation thereof, shall (i) be restricted or limited in any way by any adverse consequences (tax or otherwise) that may result
to any holder of an Award, and (ii) as, inter alia, being a feature of the Award upon its grant, be deemed to constitute a change
or an amendment of the rights of such holder under this Plan, nor shall any such adverse consequences (as well as any adverse tax consequences
that may result from any tax ruling or other approval or determination of any relevant tax authority) be deemed to constitute a change
or an amendment of the rights of such holder under this Plan.

 

		14.3.	Reservation of Rights. Except as expressly provided in this Section 14, the Grantee of an Award
hereunder shall have no rights by reason of any subdivision or consolidation of shares of any class or the payment of any stock dividend
(bonus shares), any other increase or decrease in the number of shares of any class or by reason of any dissolution, liquidation, Merger/Sale,
or consolidation, divestiture or spin-off of assets or shares of another company. Any issue by the Company of shares of any class, or
securities convertible into shares of stock of any class, shall not affect, and no adjustment by reason thereof shall be made with respect
to, the number, type or price of shares subject to an Award. The grant of an Award pursuant to the Plan shall not affect in any way the
right of power of the Company to make adjustments, reclassifications, reorganizations or changes of its capital or business structures
or to merge or to consolidate or to dissolve, liquidate or sell, or transfer all or part of its business or assets or engage in any similar
transactions.

 

		15.	NON-TRANSFERABILITY OF AWARDS; SURVIVING BENEFICIARY.

 

		15.1.	All Awards granted under the Plan shall not be transferable otherwise than by will or by the laws of descent
and distribution. Awards may be exercised or otherwise realized, during the lifetime of the Grantee, only by the Grantee or by his guardian
or legal representative, to the extent provided for herein. Any transfer of an Award not permitted hereunder (including transfers pursuant
to any decree of divorce, dissolution or separate maintenance, any property settlement, any separation agreement or any other agreement
with a spouse) and any grant of any interest in any Award to, or creation in any way of any interest in any Award by, any party other
than the Grantee shall be null and void and shall not confer upon any party or person, other than the Grantee, any rights. A Grantee may
file with the Committee a written designation of a beneficiary on such form as may be prescribed by the Committee and may, from time to
time, amend or revoke such designation. If no designated beneficiary survives the Grantee, the executor or administrator of the Grantee's
estate shall be deemed to be the Grantee's beneficiary. Notwithstanding the foregoing, upon the request of the Grantee and subject to
Applicable Law the Committee, at its sole discretion, may permit to transfer the Award to a family trust.

 

    - 19 - 

     

    

 

		15.2.	As long as the Shares are held by the Trustee in favor of the Grantee, all rights possessed by the Grantee
over the Shares are personal, and may not be transferred, assigned, pledged or mortgaged, other than by will or laws of descent and distribution.

 

		16.	CONDITIONS UPON ISSUANCE OF SHARES 

 

		16.1.	Legal Compliance. Shares shall not be issued pursuant to the exercise of an Award, unless the exercise
of such Award and the issuance and delivery of such Shares shall comply with Applicable Laws as determined by counsel to the Company.
The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s
counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect
of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.

 

		16.2.	Investment Representations. As a condition to the exercise of an Award, the Company may require
the person exercising such Award to represent and warrant at the time of any such exercise that the Shares are being purchased only for
investment and without any present intention to sell or distribute such Shares, and make other representations as may be required under
applicable securities laws if, in the opinion of counsel for the Company, such representations are required, all in form and content specified
by the Company.

 

		17.	MARKET STAND-OFF

 

		17.1.	In connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement
filed under the United States Securities Act of 1933, as amended or equivalent law in another jurisdiction, the Grantee shall not directly
or indirectly, without the prior written consent of the Company or its underwriters, (i) lend, offer, pledge, sell, contract to sell,
sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise
transfer or dispose of, directly or indirectly, any Shares acquired under this Plan or any securities of the Company (whether or not such
Shares acquired under this Plan), or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any
of the economic consequences of ownership of the Shares acquired under this Plan, whether any such transaction described in clause (i)
or (ii) above is to be settled by delivery of Shares acquired under this Plan or such other securities, in cash or otherwise. Such restriction
(the “Market Stand-Off”) shall be in effect for such period of time following the effective date of the registration statement
relating to such offering, as may be requested by the Company or such underwriters, however in any event, such period shall not exceed
180 days (in the case of the Company’s first underwritten offering of its Shares) following the effective date of such registration
statement; or 90 days (in the case of a registration statement thereafter).

 

    - 20 - 

     

    

 

		17.2.	In the event of a subdivision of the outstanding share capital of the Company, the declaration and payment
of a stock dividend (distribution of bonus shares), the declaration and payment of an extraordinary dividend payable in a form other than
stock, a recapitalization, a reorganization (which may include a combination or exchange of shares or a similar transaction affecting
the Company’s outstanding securities without receipt of consideration), a consolidation, a stock split, a spin-off or other corporate
divestiture or division, a reclassification or other similar occurrence, an adjustment in conversion ratio, any new, substituted or additional
securities which are by reason of such transaction distributed with respect to any Shares subject to the Market Stand-Off, or into which
such Shares thereby become convertible, shall immediately be subject to the Market Stand-Off.

 

		17.3.	In order to enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect
to the Shares acquired under this Plan until the end of the applicable stand-off period.

 

		17.4.	The underwriters in connection with a registration statement so filed are intended to be third party beneficiaries
of this Section ‎17 and shall have the right, power and authority to enforce the provisions hereof as though they were a party
hereto.

 

		18.	AGREEMENT BY GRANTEE REGARDING TAXES.

 

		18.1.	If the Committee shall so require, as a condition of exercise of an Award, the release of Shares by the
Trustee or the expiration of the Restricted Period, a Grantee shall agree that, no later than the date of such occurrence, he will pay
to the Company or make arrangements satisfactory to the Committee and the Trustee (if applicable) regarding payment of any applicable
taxes of any kind required by Applicable Law to be withheld or paid.

 

		18.2.	ALL TAX CONSEQUENCES UNDER ANY APPLICABLE LAW WHICH MAY ARISE FROM THE GRANT OF ANY AWARDS OR THE EXERCISE
THEREOF, THE SALE OR DISPOSITION OF ANY SHARES GRANTED HEREUNDER OR ISSUED UPON EXERCISE OF ANY AWARD OR FROM ANY OTHER ACTION OF THE
GRANTEE IN CONNECTION WITH THE FOREGOING SHALL BE BORNE AND PAID SOLELY BY THE GRANTEE, AND THE GRANTEE SHALL INDEMNIFY THE COMPANY, ITS
SUBSIDIARIES AND AFFILIATES AND THE TRUSTEE, AND SHALL HOLD THEM HARMLESS AGAINST AND FROM ANY LIABILITY FOR ANY SUCH TAX OR PENALTY,
INTEREST OR INDEXATION THEREON. EACH GRANTEE AGREES TO, AND UNDERTAKES TO COMPLY WITH, ANY RULING, SETTLEMENT, CLOSING AGREEMENT OR OTHER
SIMILAR AGREEMENT OR ARRANGEMENT WITH ANY TAX AUTHORITY IN CONNECTION WITH THE FOREGOING WHICH IS APPROVED BY THE COMPANY.

 

THE GRANTEE IS ADVISED TO CONSULT
WITH A TAX ADVISOR WITH RESPECT TO THE TAX CONSEQUENCES OF RECEIVING OR EXERCISING AWARDS HEREUNDER. THE COMPANY DOES NOT ASSUME ANY RESPONSIBILITY
TO ADVISE THE GRANTEE ON SUCH MATTERS, WHICH SHALL REMAIN SOLELY THE RESPONSIBILITY OF THE GRANTEE.

 

    - 21 - 

     

    

 

		18.3.	The Company or any Subsidiary or Affiliate may take such action as it may deem necessary or appropriate,
in its discretion, for the purpose of or in connection with withholding of any taxes which the Company or any Subsidiary or Affiliate
is required by any Applicable Law to withhold in connection with any Awards (collectively, “Withholding Obligations”).
Such actions may include, without limitation, (i) requiring a Grantees to remit to the Company in cash an amount sufficient to satisfy
such Withholding Obligations; (ii) subject to Applicable Law, allowing the Grantees to provide Shares to the Company, in an amount that
at such time, reflects a value that the Committee determines to be sufficient to satisfy such Withholding Obligations; (iii) withholding
Shares otherwise issuable upon the exercise of an Award at a value which is determined by the Committee to be sufficient to satisfy such
Withholding Obligations; or (iv) any combination of the foregoing. The Company shall not be obligated to allow the exercise of any Award
by or on behalf of a Grantee until all tax consequences arising from the exercise of such Award are resolved in a manner acceptable to
the Company.

 

		18.4.	Each Grantee shall notify the Company in writing promptly and in any event within ten (10) days after
the date on which such Grantee first obtains knowledge of any tax bureau inquiry, audit, assertion, determination, investigation, or question
relating in any manner to the Awards granted or received hereunder or Shares issued thereunder and shall continuously inform the Company
of any developments, proceedings, discussions and negotiations relating to such matter, and shall allow the Company and its representatives
to participate in any proceedings and discussions concerning such matters. Upon request, a Grantee shall provide to the Company any information
or document relating to any matter described in the preceding sentence, which the Company, in its discretion, requires.

 

		18.5.	With respect to 102 Non-Trustee Options, if the Grantee ceases to be employed by the Company or any Affiliate,
the Grantee shall extend to the Company and/or its Affiliate with whom the Grantee is employed a security or guarantee for the payment
of taxes due at the time of sale of Shares, all in accordance with the provisions of Section 102 of the Ordinance and the Rules.

 

		19.	RIGHTS AS A STOCKHOLDER; VOTING AND DIVIDENDS.

 

		19.1.	Subject to Section 11.7, a Grantee shall have no rights as a shareholder of the Company with respect to
any Shares covered by the Award until the date of the issuance of a share certificate to the Grantee for such Shares. In the case of 102
Option Awards or 3(9) Option Awards (if such Share Options are being held by a Trustee), a the Trustee shall have no rights as a shareholder
of the Company with respect to any Shares covered by such Award until the date of the issuance of a share certificate to the Grantee for
such Shares for the Grantee’s benefit, and the Grantee shall have no rights as a shareholder of the Company with respect to any
Shares covered by the Award until the date of the release of such Shares from the Trustee to the Grantee and the issuance of a share certificate
to the Grantee for such Shares. No adjustment shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other
property) or distribution of other rights for which the record date is prior to the date such share certificate is issued, except as provided
in Section 14 hereof.

 

		19.2.	With respect to all Shares issued in the form of Awards hereunder or upon the exercise of Awards hereunder,
any and all voting rights attached to such Shares shall be subject to Section 6.9, and the Grantee shall be entitled to receive dividends
distributed with respect to such Shares, subject to the provisions of the Company’s Articles of Association, as amended from time
to time, and subject to any Applicable Law.

 

		19.3.	The Company may, but shall not be obligated to, register or qualify the sale of Shares under any applicable
securities law or any other applicable law.

 

    - 22 - 

     

    

 

		20.	NO REPRESENTATION BY COMPANY.

 

By granting the Awards, the Company
is not, and shall not be deemed as, granting any representation or warranties to the Grantee regarding the Company, its business affairs,
its prospects or the future value of its Shares.

 

		21.	NO RETENTION RIGHTS.

 

Nothing in the Plan or in any Award
granted or agreement entered into pursuant hereto shall confer upon any Grantee the right to continue in the employ of, or be in a consultant,
advisor, director, officer or supplier relationship with, the Company or any Subsidiary or Affiliate or to be entitled to any remuneration
or benefits not set forth in the Plan or such agreement or to interfere with or limit in any way the right of the Company or any such
Subsidiary or Affiliate to terminate such Grantee's employment or service. Awards granted under the Plan shall not be affected by any
change in duties or position of a Grantee as long as such Grantee continues to be employed by, or be in a consultant, advisor, director,
officer or supplier relationship with, the Company or any Subsidiary or Affiliate.

 

		22.	PERIOD DURING WHICH AWARDS MAY BE GRANTED.

 

Awards may be granted pursuant to
the Plan from time to time within a period of ten (10) years from the Effective Date. From the tenth (10th) anniversary of
the Effective Date no grants of Awards may be made and the Plan shall continue to be in full force and effect solely with respect to such
Awards that remain outstanding. The Plan shall terminate at such time at such time after the tenth (10th) anniversary of the
Effective Date that no Awards remain outstanding.

 

		23.	TERM OF AWARD

 

Anything herein to the contrary notwithstanding,
but without derogating from the provisions of Sections 6.6, 6.7 or 8.2 hereof, if any Award, or any part thereof, has not been exercised
and the Shares covered thereby not paid for within the term of the Award as determined by the Committee, which in any event shall not
exceed ten (10) years after the date on which the Award was granted, as set forth in the Notice of Grant in the Grantee’s Award,
such Award, or such part thereof, and the right to acquire such Shares shall terminate, and all interests and rights of the Grantee in
and to the same shall expire. In the case of Shares held by a Trustee, the Grantee shall elect whether to release such Shares from trust
or sell the Shares and upon such release or sale such trust shall expire.

 

		24.	AMENDMENT AND TERMINATION OF THE PLAN.

 

The Board at any time and from time
to time may suspend, terminate, modify or amend the Plan, whether retroactively or prospectively; provided, however, that, unless otherwise
determined by the Board, an amendment which requires shareholder approval in order for the Plan to continue to comply with any Applicable
Law shall not be effective unless approved by the requisite vote of shareholders, and provided further that except as provided herein,
no suspension, termination, modification or amendment of the Plan may adversely affect any Award previously granted, unless the written
consent of the respective Grantee is obtained.

 

		25.	APPROVAL.

 

		25.1.	The Plan shall take effect upon its adoption by the Board (the “Effective Date”), except
that solely with respect to grants of Incentive Stock Options the Plan shall also be subject to approval within one year of the Effective
Date, by a majority of the votes cast on the proposal at a meeting or a written consent of shareholders. Failure to obtain approval by
the shareholders shall not in any way derogate from the valid and binding effect of any grant of an Award, which is not an Incentive Stock
Option. Upon approval of the Plan by the shareholders of the Company as set forth above, all Incentive Stock Options granted under the
Plan on or after the Effective Date shall be fully effective as if the shareholders of the Company had approved the Plan on the Effective
Date. Notwithstanding the foregoing, in the event that approval of the Plan by the shareholders of the Company is required under Applicable
Law, in connection with the application of certain tax treatment or pursuant to applicable stock exchange rules or regulations or otherwise,
such approval shall be obtained within the time required under the Applicable Law.

 

    - 23 - 

     

    

 

		25.2.	The 102 Awards are subject to the approval, if required, of the ITA and receipt by the Company of all
approvals thereof.

 

		26.	RULES PARTICULAR TO SPECIFIC COUNTRIES 

 

Notwithstanding
anything herein to the contrary, the terms and conditions of the Plan may be amended with respect to a particular country by means of
an appendix to the Plan, and to the extent that the terms and conditions set forth in any appendix conflict with any provisions of the
Plan, the provisions of the appendix shall govern. Terms and conditions set forth in the Appendix shall apply only to Award granted to
a Grantee under the jurisdiction of the specific country that is the subject of the appendix and shall not apply to Awards issued to a
Grantee not under the jurisdiction of such country. The adoption of any such appendix shall be subject to the approval of the Board of
Directors or Committee, and if required in connection with the application of certain tax treatment, pursuant to applicable stock exchange
rules or regulations or otherwise, then also the approval of the shareholders of the Company at the required majority.

 

		27.	GOVERNING LAW; JURISDICTION.

 

The Plan and all determinations made
and actions taken pursuant hereto shall be governed by the laws of the State of Israel, except with respect to matters that are subject
to tax laws, regulations and rules in any specific jurisdiction, which shall be governed by the respective laws, regulations and rules
of such jurisdiction. Certain definitions, which refer to laws other than the laws of such jurisdiction, shall be construed in accordance
with such other laws. The competent courts located in Tel-Aviv-Jaffa, Israel shall have exclusive jurisdiction over any dispute arising
out of or in connection with this Plan and any Award granted hereunder, and by signing any agreement relating to an Award hereunder each
Grantee irrevocably submits to such exclusive jurisdiction.

 

		28.	NON-EXCLUSIVITY OF THE PLAN.

 

Neither the adoption of the Plan by
the Board nor the submission of the Plan to shareholders of the Company for approval (to the extent required under Applicable Law), shall
be construed as creating any limitations on the power or authority of the Board to adopt such other or additional incentive or other compensation
arrangements of whatever nature as the Board may deem necessary or desirable or preclude or limit the continuation of any other plan,
practice or arrangement for the payment of compensation or fringe benefits to employees generally, or to any class or group of employees,
which the Company or any Subsidiary now has lawfully put into effect, including, without limitation, any retirement, pension, savings
and stock purchase plan, insurance, death and disability benefits and executive short-term or long-term incentive plans.

 

		29.	MISCELLANEOUS.

 

		29.1.	Additional Terms. Each Award awarded under the Plan may contain such other terms and conditions
not inconsistent with the Plan as may be determined by the Committee, in its sole discretion.

 

		29.2.	Severability. If any provision of the Plan or any Award Agreement shall be determined to be illegal
or unenforceable by any court of law in any jurisdiction, the remaining provisions hereof and thereof shall be severable and enforceable
in accordance with their terms, and all provisions shall remain enforceable in any other jurisdiction. In addition, if any particular
provision contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographic scope, activity
or subject, it shall be construed by limiting and reducing such provision as to such characteristic so that the provision is enforceable
to fullest extent compatible with the applicable law as it shall then appear.

 

		29.3.	Captions and Titles. The use of captions and titles in this Plan or any Option Agreement, Restricted
Share Agreement or other Award related agreement is for the convenience of reference only and shall not affect the meaning of any provision
of the Plan or such agreement.

 

*      *      *

 

 

- 24 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]